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HUIYAN SUN

Under the Direction of Zhen Huang

ABSTRACT
The atom-specific modification has been extensively applied in RNA function and
structure investigations, catalysis analysis, mechanism studies, as well as therapeutics
discoveries. Selenium-modified uridine (SeU-RNA) is one of the naturally occurring
modifications that was discovered in bacterial tRNAs (SeU-RNA) at the wobble position of the
anticodon loop. Its exact role in the RNA-RNA interaction, especially during the mRNA
decoding is not completely understood but it was proposed that such Se derivatization on tRNAs
probably improves the accuracy and efficiency of base-pairing. The wobble base pairs, where U
in RNA (or T in DNA) pairs with G instead of A, might compromise the high specificity of the
base pairing. The U/G wobble pairing is ubiquitous in RNA, especially in non-coding RNA. To

assist the research exploration, we have hypothesized to discriminate against U/G wobble pair by
tailoring the steric and electronic effects at the 2-exo position of uridine base and replacing 2-exo
oxygen with a selenium atom. This oxygen replacement with selenium offers a unique chemical
strategy to enhance the base pairing specificity at the atomic level. Here, we report the first
synthesis of the 2-Se-U-RNAs through synthetic incorporation of 2-Se-uridine (SeU)
phosphoramidite as well as enzymatic incorporation of 2-Se-uridine triphosphate. Our
biophysical and structural studies of the SeU-RNAs indicate that this single atom replacement can
indeed create a novel U/A base pair with higher specificity than the natural one. We reveal that
the

Se

U/A pair maintains a structure virtually identical to the native U/A base pair, while

discriminating against U/G wobble pair. Moreover, we have demonstrated that the synthesized
Se

UTPs (2-Se-UTP and 4-Se-UTP) are stable and recognizable by T7 RNA polymerase.

Furthermore, the transcribed

Se

U-hammerhead ribozyme has the similar activity as the

corresponding native, which suggests usefulness of

Se

U-RNAs in function and structure studies

of noncoding RNAs, including the Se-tRNAs.
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Hammerhead ribozyme
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1
1.1

GENERAL INTRODUCTION

RNA and RNA Modification
The text of this work has been published as “Atom-specific Mutagenesis of RNAs for

Structure, Function and Therapeutics Studies”, RNA Nanotechnology and Therapeutics, John
Wiley & Sons, Inc., 2013, 213-234. I would like to acknowledge Dr. Zhen Huang for his
intellectual contribution as a co-author.
Since RNAs are involved in complex biological processes as regulators, their diversities
in both function and structure have been greatly appreciated.1 RNA possesses not only the ability
to store genetic information and participate in transcription and translation but also the capacity
to adopt well-defined three-dimensional structures, which can be readily adjusted to meet various
functional needs.2 Although the importance of numerous RNAs in catalysis, gene expression,
protein binding, and therapeutics3 has been acknowledged by the entire scientific society, current
understanding of RNA function and structure is still limited. Thus, it is not a coincidence that
RNA modifications have become the subject of very intensive and active research.4
Over a hundred modified nucleoside residues have been discovered in natural RNAs,5
including simple methylation, isomerization, and single-atom modification. These modifications
alter the biophysical and biochemical properties of RNA structure and function. Most of these
modifications are found in transfer RNAs (tRNA) despite the fact that the precise roles of many
natural modifications remain mysterious. To synthesize RNAs containing modifications on the
nucleobases, sugars, and phosphate backbone, both chemical and enzymatic strategies can be
pursued.6 Modified nucleic acids have tremendous potential for functional and structural
investigations as well as for drug discovery, especially when equipped with unique properties,

2

such as enhanced thermal stability,7 nuclease resistance,8 and improved bio-availability.
1.2

Atom Specific Modification
Atom-specifically modified or substituted RNAs can offer many unique and novel

properties without significant perturbation of three-dimensional structures and structural features
of noncoding RNAs and RNA–protein complexes.9 Hydrogen (H), carbon (C), nitrogen (N), and
oxygen (O) are the four fundamental organic elements that establish nucleobases and sugars,
while phosphorus (P) exists in the nucleic acid backbone. These five essential elements
constitute the frame of nucleic acids. Single-atom replacement (or atom-specific mutagenesis) of
nucleic acids substitutes one nucleotide atom with another atom from the same element family
(such as O, S, Se, and Te) or an equivalent atom. Atom-specific mutagenesis of RNA provides
useful tools to investigate RNA folding, study RNA–RNA and RNA–protein interactions,
improve biochemical and biophysical properties of RNAs, facilitate gene delivery in RNA
nanotechnology and drug discovery, and explore potential RNA therapeutics.4, 10
Among the atom-specific modifications, sulfur and selenium are in the same family with
oxygen, thereby sharing similar physical and chemical properties, such as atomic radius (O: 0.73
Å; S: 1.02 Å; Se: 1.16 Å).11 In principle, every oxygen atom on nucleic acids can be replaced by
sulfur or selenium, and in practice, almost all of the oxygen atoms on the nucleobases, sugar, and
phosphate backbone have been chemically or enzymatically replaced with sulfur or selenium
atoms (Figure 1.2.1). This is a great advantage of chalcogen modification in comparison with
halogen modification (except for fluorine), due to their instability as good leaving groups. In
general, only the C-5 of pyrimidines, C-8 of purines and C-2 of adenosine are appropriate
locations for the halogen substitutions. Moreover, the sulfur and selenium modifications have
been discovered in natural RNAs. Incorporation of the S and Se modifications into

3

oligonucleotides via synthetic and enzymatic methodologies can help uncover the roles of such
naturally occurring modifications in order to utilize them in related research area and drug
discovery. Furthermore, it is noteworthy to mention that the element tellurium, which belongs to
the chalcogen family with oxygen, sulfur and selenium, but has a much larger size (atomic
radius: 1.40 Å) and more metallic character, has been introduced into sugar and base moieties of
DNA.12 The tellurium–DNA demonstrated strong topographic and current peaks through STM
(Scanning Tunneling Microscope) imaging, which opens a new approach to image nucleic acids
and their complexes with proteins and small molecule ligands.

Figure 1.2.1. Sulfur and selenium modifications on RNA nucleobases.
The asterisk (*) indicates naturally occurring compounds.
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1.2.1

Sulfur Modification
Sulfur is in the same family with oxygen and is one of the essential elements in

organisms involved in biological processes. In nature, sulfur-containing nucleobases, including
2-thiouridine (s2U), 4-thiouridine (s4U) and 2-thiocytidine (s2C), are observed and isolated in
yeast and Escherichia coli tRNAs as minor components (Figure 1.2.2).13 2-Thionyl modified
uridine was discovered back in the 1960s and often found with additional modifications at the C5-position. These 2-thiouridine derivatives occur at wobble position 34 of E. coli transfer RNA
(tRNAGlu, tRNALys, and tRNAGln) as well as human tRNALys and are involved in codon–
anticodon interaction during protein translation.14 Biophysical studies showed that the s2U
exhibits better thermostability, compared to the native one.7, 15 In vitro experiment indicated that
2-thiouridine derivatives in tRNA prefer A over G at wobble position 34.16 An additional study
carried out by Ashraf and coworkers shows that the site-specific substitution of 2-thiouridine in
tRNA has higher affinity in binding to ribosome, compared to unmodified tRNA despite the
modifications on C-5,17 which has thus highlighted the functional importance of s2U mutation.
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Se
O
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N

Se
O

O

OH

2-selenouridine

OH

OH

5-methylamino-methyl-2-selenouridine
(mnm5se2U)

Figure 1.2.2. Cloverleaf structure of E. coli tRNAGlu.
N represents mnm5s2U in E.coli tRNAGlu and mnm5se2U in C. sticklandii seleno-tRNAGlu.
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1.2.2

Selenium Modification
Element selenium belongs to chalcogen group in the periodic table together with oxygen

and sulfur. Although selenium shares similar electronic and chemical properties with oxygen and
sulfur, their subtle differences determine their distinct applications in biological processes and
systems. Similar to sulfur, selenium-modified nucleobases are naturally occurring compounds
that exist in many bacterial tRNAs, such as Escherichia coli, Clostridium sticklandii,
Methanococcus vannielii, etc..5 The Se modification is often found at the wobble position
(position 34) of anticodon loop, which is essential for mRNA decoding.18 The seleno nucleobases
were identified as 2-selenouridine derivatives with modifications on position C-5, such as 5aminomethyl, 5-carboxymethylaminomethyl, 5-formyl, and 5-methylaminomethyl functionalities
(Figure 1.2.2), decades ago. However, the exact role of selenium at position C-2 is not yet clear.
Since it was hypothesized that the 2-Se functionality discourages the U/G wobble pairing but
does not affect U/A Watson-Crick base pairing (Figure 2.1.1), the 2-Se functionality is able to
improve RNA base pair fidelity, thereby enhancing the accuracy of RNA transcription and
translation. The 2-Se-uridine-containing RNA was chemically synthesized by Huang’s lab to
further explore the functionality of the seleno modification.9a Consistent with their hypothesis,
our study showed that with the introduction of selenium at the 2-position, the Se–RNA duplex
structure is virtually identical to the corresponding native form. The U/G wobble pair was greatly
discouraged due to the large size of selenium atom and poor electronegativity, which severely
weakened the hydrogen bonding, while the U/A base pair was not significantly affected. Thus,
the increased fidelity of U/A base pairing provided new insights into codon–anticodon
recognition with the seleno modification at the third codon base. Moreover, the 2-selenouridinemodified hammerhead ribozyme has catalytically activity.19 The Se-modified thymidine at
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position 420 and guanosine at position 621 in DNA oligonucleotides were also reported recently.
In addition, the 4-Se-U RNA has been synthesized in the laboratory recently.22 In natural RNA,
4-selenouridine was reported earlier in E. coli tRNA,23 and the later studies suggested the 4-Se
functionality as a misincorporation.24 Furthermore, 6-selenoguanine has been applied in
anticancer therapeutic studies in comparison with 6-thioguanine, and it showed promising
antitumor activity against L1210 lymphomas, L5178Y lymphomas, and Sarcoma 180,25 while no
encouraging result was observed yet in the treatment of solid tumors.26
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2
2.1

HIGHER SPECIFICITY OF RNA BASE PAIRING

Introduction
The text of this work has been published as “Novel RNA Base Pair with Higher

Specificity using Single Selenium Atom”, Nucleic Acids Res., 2012, 40, 5171-5179. I would like
to acknowledge Dr. Jia Sheng, Dr. Sibo Jiang and Dr. Jianhua Gan for their contribution in RNA
structure determination as co-authors, and I would like to acknowledge Dr. Zhen Huang and Dr.
Abdalla E. A. Hassan for their intellectual contribution as co-authors.
2.1.1

U/G wobble pair
DNA and RNA are crucial genetic information carriers.27 The base pairs of DNAs (T/A

and C/G) and RNAs (U/A and C/G) need to be highly specific and accurate for the purpose of
the precise genetic information storage, replication, transcription and translation. However, the
wobble base pairs, where U in RNA (or T in DNA) pairs with G instead of A, may compromise
the high specificity of the base pairing. In RNA, especially non-coding RNA, U/G wobble pair
(Figure 2.1.1) is ubiquitous28 and sometimes it has the similar stability as the Watson–Crick U/A
pair.29 U/G wobble pair offers unique structural and thermodynamic features.28-29 On the one
hand, the U/G pairing increases structure and function diversities of RNA.30 But on the other
hand, it may jeopardize the pairing specificity and can cause potential mutations in RNA
transcription and protein translation. Codon–anti- codon mismatch or misreading is observed
with an error frequency at 10-5 or higher, which may affect the accuracy of synthesized
proteins.31 For instance, the first position of the codon–anticodon interaction with wobble
mismatch (U/G) was discovered in Escherichia coli (error frequency = 0.1%) with 100-fold
higher than the normal error level.31c In this mis-incorporation of serine (codon: AGC),31c glycine
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codon (GGC) in mRNA is recognized by Ser-charged tRNA (anticodon: GCU) instead of Glycharged tRNA (anticodon: GCC). Similarly, the second position of the codon–anticodon
interaction with wobble mismatch (U/G) was also observed, where Lys (codon: AAA) is misincorporated instead of normal incorporation of Arg (codon: AGA), with much higher error
frequency (5–12%).32 To avoid the negative impact of the wobble pairing on the level of protein
synthesis, the genetic codes with degeneracy are used to deal with the consequence of the wobble
pairing. Thus, wobble pairing is often observed at the third codon position through the codon
degeneracy to limit errors. However, the codons forming the Watson–Crick pairs with tRNA
anticodons are still preferred.33 Study shows that the third codon position with a Watson–Crick
base pair can reduce the frequency of amino acid mis-incorporation by nearly 10-fold, and it is
much more accurate than that with a wobble pair for the same amino acid.34 Nevertheless, the 3nt genetic codes that accommodate the wobble pairing are used as the most ideal countermeasure at the level of protein synthesis in living organisms.35 Clearly, on the basis of the
chemical principle, this degeneracy strategy properly guarantees the translation accuracy at the
protein level by tolerating wobble pairs and silent mutations at the RNA and DNA levels.

Figure 2.1.1. Native and Se-modified U/A pairs and U/G wobble pairs.
Selenium substitution for the oxygen atom was labeled in red.

9

2.1.2

Sulfur- and selenium-modified wobble pair

Since the 2-exo-oxygen of uridine plays a significant role in U/G wobble pair, we hypothesized
that tailoring the steric and electronic effects at this site may discriminate against the wobble
pair, enabling the modified U/A base pair with higher specificity. Interestingly, selenium has
been discovered in natural tRNAs in the 2-Se-uridine form, i.e. 5-methylaminomethyl-2selenouridine (mnm5se2U), in the wobble position on the anticodon loop.18, 24 The function of
such selenium modification is not completely clear yet, though it was proposed that such Se
derivatization on tRNAs probably improves the accuracy and efficiency of protein translation.36
Similarly, the corresponding sulfur modification has been observed on natural tRNAs.37 Sulfur
was chemically introduced to the 2-position of uridine.38 The S-modified U/G pair is slightly less
stable than the native U/G pair,29b while the SU/A is more stable over the native U/A pair. Thus,
we hypothesized that the 2-oxygen replacement with selenium (SeU, Figure 2.1.1) can destabilize
and discriminate against the U/G wobble pair, because the atomic size of selenium (1.16 Å) is
larger than that of sulfur (1.02 Å) and oxygen (0.73 Å). Moreover, selenium has the least ability
to form a hydrogen bond among O, S and Se, which weakens the hydrogen bond originally
formed by the 2-oxygen of the wobble pair. Thus, it is expected that this 2-Se-replacement can
largely destabilize U/G pair by generating a steric hindrance against the pair and significantly
weakening the hydrogen bond. Furthermore, it is expected that the 2-Se-substitution does not
significantly affect the hydrogen bonds within the U/A pair, since the 2-oxygen is not directly
involved in the U/A base pairing. Therefore, we decided to incorporate selenium into the 2position of uridine in RNA, in order to atom-specifically increase the U/A pair specificity and
disrupt the U/G wobble.
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2.2
2.2.1

General Experimental Section
Synthesis of 2-Se-uridine phosphoramidite
Though selenium was incorporated into uridine four decades ago,39 RNA containing 2-

Se-uridine (SeU) hasn’t been synthesized because of the synthetic challenge. Recently our
laboratory has successfully developed a novel strategy to incorporate the selenium functionality
to the 2-position of thymidine in DNA.40 This successful strategy has encouraged us to introduce
the selenium functionality to the 2-position of uridine in RNA. Herein we report the first
synthesis of the 2-selenouridine derivatives and RNAs. The synthesis (Scheme 2.2.1) started
from the glycosidation of 1 with silylated 2-thiouracil (3), followed by benzoyl deprotection and
trityl protection of the 5’-hyroxyl group to offer 6.41 After methylation of 6 to activate the 2-thiofunctionality,40 NaSeH was used to displace the 2-S-functionality and offer the 2-Se-uridine (8)
in 85% yield. Following the protections of the 2’-hydroxyl group and the 2-Se-functionality with
ICH2CH2CN, the Se-phosphoramidite (11) was synthesized by phosphitylation of 10a.40, 42 The
Se

U-phosphoramidite was finally incorporated into RNAs by solid-phase synthesis. The

synthesized SeU-RNAs (12) were deprotected, purified, and confirmed by HPLC and MS (Figure
2.2.3,Table 2.2.1). For the purpose of comparison, the corresponding S-modified RNA was also
synthesized by following the literature41 and characterized by HPLC and MS analyses (Table
2.2.1, Figure 2.2.3).
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Scheme 2.2.1. Synthesis of 2-Se-Uridine containing RNA.
Reagents and conditions: a) TMS-Cl, HMDS, reflux; b) SnCl4, C2H4Cl2, -20oC; c) NaOCH3,
MeOH; d) DMTr-Cl, pyridine, rt. (e) CH3I, DBU, DMF; (f) Se, NaBH4, EtOH; (g) TBDMS-Cl,
imidazole, DMF; (h) ICH2CH2CN, (i-Pr)2NEt, CH2Cl2; (i) (i-Pr2N)2P(Cl)OCH2CH2CN, (iPr)2NEt, CH2Cl2; (j) solid-phase synthesis.

2.2.1.1 Synthesis of compound 4
1-(2’,3’,5’-tri-O-benzoyl-beta-D-ribofuranosyl)-2-thiouridine (Compound 4).
4-[(trimethylsilyl)oxy]-2-[(trimethylsilyl)thio]-pyrimidine 2 was synthesized7, 43 by the
silylation of 2-thiouracil 1 (3.81 g, 29.76 mmol) with hexamethyldisilazane (HMDS, 100 mL)
and catalytic amount of trimethylsilyl chloride (TMSCl, 0.5 mL) under reflux condition
overnight until a clear yellow solution was obtained. The excess of HMDS and TMSCl was
evaporated under reduced pressure. 1-O-Acetyl-2,3,5-tri-O-benzoyl-bata-D-ribofuranose 3 (10 g,
19.82 mmol) was dissolved in 1,2-dichloroethane (99 mL), then it was added to the concentrated
silylated 2-thiouracil 2. Tin (IV) chloride (6.9 mL) was subsequently added at -20 oC under
nitrogen. The reaction was stirred for 5 hours and poured into a saturated aqueous sodium
bicarbonate solution with stirring. After 1 hour, the suspension was extracted with
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dichloromethane (6x50 mL). The organic layers were combined and dried over anhydrous
magnesium sulfate, followed by filtration and evaporation under reduced pressure. The crude
compound was purified by column chromatography (1% methanol in dichloromethane), offering
4 as a white foam (10.5 g, 85% yield). The compound was analyzed by 1H NMR and its chemical
shifts were consistent with the known compound44. 1H NMR (400 MHz, CDCl3) δ 10.30 (s, 1H,
NH), 8.13 – 8.05 (m, 2H, Ar), 8.05 – 7.97 (m, 2H, Ar), 7.96 – 7.89 (m, 2H, Ar), 7.70 (d, J = 8.2
Hz, 1H, H-6), 7.65 – 7.49 (m, 5H, Ar), 7.43 – 7.35 (m, 4H, Ar), 7.28 (d, J = 4.7 Hz, 1H, H-1’),
5.84 – 5.76 (m, 3H, H-5, H-2’,H-3’), 4.88 (dd, J = 12.6, 2.5 Hz, 1H, H-5’), 4.78 (dt, J = 5.3, 2.8
Hz, 1H, H-4’), 4.69 (dd, J = 12.6, 3.1 Hz, 1H, H-5’).

2.2.1.2 Synthesis of compound 5
2-thio-1-beta-D-ribofuranosylpyrimidine-2,4-dione (Compound 5).
Compound 4 (10.5 g, 18.35 mmol) was dissolved in methanol (92 mL) and sodium
methoxide (5.95 g, 0.11 mol) was added to the solution. After stirring for 6 hours, the solution
was neutralized by adding DOWEX 50WX8-400 ion-exchange resin (H+-form, approximately
110 meq until neutral, monitored by moisturized pH paper) washed with methanol. The mixture
was filtered and methanol was evaporated. The residue was suspended with water (100 mL) and
extracted with ethyl acetate (2x30 mL). Water layer was lyophilized (or evaporated under
reduced pressure) to give deprotected nucleoside 5. The crude product was monitored by TLC
plate (20% methanol in dichloromethane, Rf = 0.4) to confirm the removal of the by-product,
methyl benzoate. The crude product was purified by recrystallization in ethanol and gave a white
powder. The compound was analyzed by 1H NMR and its chemical shifts were consistent with
the known compound (Ref. 1,2). 1H NMR (D2O) δ: 8.15 (d, J = 8.2 Hz, 1H, H-6), 6.64 (d, J =
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2.4 Hz, 1H, H-1’), 6.20 (d, J = 8.2 Hz, 1H, H-5), H-4’ overlap with HOD signal, 4.41 (m, 1H, H3’), 4.22 (d, J = 2.4 Hz, H-2’), 4.04 -3.89 (m, 2H, H-5’).

2.2.1.3 Synthesis of compound 6
1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine (Compound 6).
2-thiouridine 5 (3 g, 11.54 mmol) and 4, 4’-dimethoxytrityl chloride (DMTr-Cl, 4.69 g,
13.85 mmol) were dried individually under high vacuum. A solution of DMTr-Cl dissolved in
anhydrous pyridine (15 mL) was slowly added to 5 dissolved in anhydrous pyridine (40 mL)
under nitrogen gas, at 0 oC. The mixture was stirred for three hours at room temperature and
methanol (5 mL) was then added to the mixture to quench the reaction. Pyridine was evaporated
under reduced pressure and co-evaporated with toluene (20 mL) for 3 to 4 times. The residue
was dissolved with ethyl acetate (30 mL) and washed with water twice (20 mL). The organic
phase was dried over anhydrous magnesium sulfate, filtered and evaporated to dryness.
Purification was carried out by flash column chromatography (2% methanol in dichloromethane)
pre-equalized by 1% triethylamine in dichloromethane before sample loaded. Compound 6, a
yellow form was obtained (5 g, 80% yield; 31). 1H NMR (CDCl3) δ: 11.02 (s, 1H, NH), 8.23 (d,
J = 8.2 Hz, 1H, H-6), 7.44 – 7.13 (m, 9H, Ar), 6.83 (m, 4H, Ar), 6.43 (s, 1H, H-1’), 5.55 (d, J =
8.2 Hz, 1H, H-5), 4.50 (m, 1H, H-4’), 4.43 (m, 1H, H-3’), 4.35 (s, 1H, OH), 4.19 (d, J = 7.4 Hz,
1H, H-2’), 3.75 (d, J = 1.7 Hz, 6H, OCH3), 3.56 (dd, J = 20.8, 9.5 Hz, 2H, H-5’), 3.41 (br, 1H,
OH); 13C NMR (CDCl3) δ: 175.32 (C-2), 160.70 (C-4), 158.79 (Ar), 144.43 (Ar), 141.08 (C-6),
135.37 (Ar), 135.15 (Ar), 130.30 (Ar), 130.22 (Ar), 128.25 (Ar), 128.19 (Ar), 127.33 (Ar),
113.48 (Ar), 106.75 (C-5), 94.37 (C-1’), 87.22 (C-Ar3), 83.78 (C-4’), 75.80 (C-2’) , 69.17 (C-3’)
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, 61.21 (C-5’), 55.40 (OCH3); HRMS (ESI-TOF) [M-H+]- = 561.1718 (calc. 561.1695), Chemical
Formula: C30H29N2O7S.

2.2.1.4 Synthesis of compound 7
1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-methylthiouridine (Compound 7).
Dry compound 6 (5 g, 8.89 mmol) was dissolved in dry N, N-dimethylformamide (DMF),
followed by addition of iodomethane (5.5 mL, 89 mmol). 1,8-diazabicyclo[5.4.0]undec-7-ene (2
mL, 13.3 mmol) was then added to the reaction mixture at 0 oC. The reaction was monitored by
TLC plate (12% methanol in dichloromethane, Rf = 0.4) and completed in 4 hours. Ethyl acetate
(50 mL) was poured into the mixture and DMF was removed by washing the organic layer with
saturated sodium chloride solution. The organic phase was dried over anhydrous magnesium
sulfate and evaporated under reduced pressure. The residue was purified by flash column
chromatography (10% methanol in dichloromethane) and pure compound 7 was obtained in 95%
yield. 1H NMR (CDCl3) δ: 7.87 (d, J = 7.7 Hz, 1H, H-6), 7.44-7.20 (m, 9H, Ar), 6.85 (m, 4H,
Ar), 6.11 (br, 1H, OH), 5.88 (d, J = 6.0 Hz, 1H, H-1’), 5.54 (d, J = 7.7 Hz, 1H, H-5), 4.63 (m,
1H, H-4’), 4.44 (m, 1H, H-3’), 4.24 (d, J = 2.3 Hz, 1H, H-2’), 3.75 (d, J = 3.1 Hz, 6H, OCH3),
3.42 (m, 2H, H-5’), 3.40 – 3.30 (br, 1H, OH), 2.55 (s, 3H, SCH3); 13C NMR (CDCl3) δ: 169.19
(C-4), 164.36 (C-2), 158.88 (Ar), 144.49 (Ar), 140.13 (C-6), 135.37 (Ar), 135.22 (Ar), 130.41
(Ar), 130.28 (Ar), 128.32 (Ar), 128.28 (Ar), 127.29 (Ar), 113.54 (Ar), 108.92 (C-5), 91.95 (C1’), 87.35 (C-Ar3), 84.82 (C-4’), 75.24 (C-2’), 71.63 (C-3’), 63.40 (C-5’), 55.40 (OCH3), 15.39
(SCH3); HRMS (ESI-TOF) [M+H+]+ = 577.2003 (calc. 577.2008), Chemical Formula:
C31H33N2O7S.
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2.2.1.5 Synthesis of compound 8
1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-selenouridine (Compound 8).
A solution of NaSeH was generated by addition of absolute ethanol (50 mL) to selenium
(6.2 g, 78 mmol) and sodium borohydride (NaBH4, 4.43 g, 0.117 mol) at 0 oC. The reaction was
completed in two hours and a clear solution was formed. The ethanolic solution was added to
compound 7 (4.5 g, 7.80 mmol) and the mixture was stirred for eight hours under argon. The
reaction mixture was then concentrated under reduced pressure and ethyl acetate (50 mL) was
added to the residue. The organic layer was washed with water several times (5x30 mL), and
then dried over anhydrous magnesium sulfate. Purification was performed by flash column
chromatography (4% methanol in dichloromethane) and the light yellow compound (8) was
obtained (85% yield). 1H NMR (CDCl3) δ: 10.95 (s, 1H, NH), 8.24 (d, J = 8.2 Hz, 1H, H-6), 7.44
– 7.19 (m, 9H, Ar), 6.84 (m, 4H, Ar), 6.48 (s, 1H, H-1’), 5.66 (d, J = 8.1 Hz, 1H, H-5), 4.48 (m,
2H, H-4’,H-3’), 4.22 (m, 1H, H-2’), 3.89 (s, 1H, OH), 3.79 (s, 6H, OCH3), 3.58 (dd, J = 23.6, 9.2
Hz, 2H, H-5’), 2.97 (br, 1H, OH); 13C NMR (CDCl3) δ: 175.74 (C-2), 159.21 (C-4), 158.98 (Ar),
158.94 (Ar), 144.45 (Ar), 140.82 (C-6), 135.38 (Ar), 135.18 (Ar), 130.35 (Ar), 130.27 (Ar),
128.30 (Ar), 128.28 (Ar), 127.45 (Ar), 113.58 (Ar), 108.37 (C-5), 96.86 (C-1’), 87.38 (C-Ar3),
84.41 (C-4’), 76.33 (C-2’), 69.19 (C-3’), 61.20 (C-5’), 55.48 (OCH3). HRMS (ESI-TOF) [M-H+]=609.1136 (calc. 609.1140), Chemical Formula: C30H29N2O7Se; UV (MeOH): λmax = 311 nm (in
methanol).
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2.2.1.6 Synthesis of compound 9
1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2selenouridine (Compound 9a) and 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytritylbeta-D-ribofuranosyl)-2-selenouridine (Compound 9b).
5’-DMTr-2-selenouridine 8 (0.5 g, 0.82 mmol) was dissolved in dry N,Ndimethylformamide, then tert-butyldimethylsilyl chloride (TBDMSCl, 0.15 g, 0.98 mmol) and
imidazole (0.11 g, 1.64 mmol) were added into the solution under nitrogen gas. The reaction was
monitored by TLC plate (15% ethyl acetate in dichloromethane, Rf = 0.8). The mixture was
stirred overnight at room temperature and then directly poured into ethyl acetate (20 mL) and
washed with water (2x20 mL). The organic layer was dried by anhydrous magnesium sulfate and
evaporated under reduced pressure. Two compounds, 9a and 9b, were obtained. The two
regional isomers (ratio 1:1) were purified together by flash column chromatography (10% ethyl
acetate in dichloromethane) and were not further separated. Since it was both challenging and
unnecessary to separate each isomer, we decided to move to the next step of synthesis without
separation of these two isomers. HR-MS (ESI-TOF, 9a and 9b) [M-H+]- = 723.1990 (calc.
723.2005). Chemical Formula: C36H43N2O7SeSi.
2.2.1.7 Synthesis of compound 10
1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2cyanoethylselanyluridine

(Compound

10a)

and

1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-

dimethoxytrityl-beta-D-ribofuranosyl)-2-cyanoethylselanyluridine (Compound 10b).
The mixture (0.52 g, 0.72 mmol) of 9a and 9b was dissolved in dried dichloromethane at
0oC. Iodopropionitrile (0.78 g, 4.31 mmol) was added to the solution, followed by addition of
diisopropylethylamine (0.37 mL, 2.15 mmol). The reaction was monitored by TLC plates (30%
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Ethyl acetate in dichloromethane). After 4 hrs reaction, the solvent was removed under reduced
pressure and the residue was partitioned between ethyl acetate (20 mL) and water (20 mL). The
organic phase was dried over anhydrous magnesium sulfate and evaporated into dryness. Two
crude products were obtained: 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-Dribofuranosyl)-2-cyanoethylselanyluridine 10a (Rf = 0.35) and 1-(3’-O-tert-butyldimethylsilyl5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-cyanoethylselanyluridine 10b (Rf = 0.30).
These two compounds can be separated by flash column chromatography (15% ethyl acetate in
dichloromethane). 10a was obtained in 0.228 g (41% yield) and 10b was obtained in 0.235 g
(42% yield). 10a: 1H NMR (CDCl3) δ: 7.96 (d, J = 7.7 Hz, 1H, H-6), 7.53 – 7.11 (m, 9H, Ar),
6.85 (m, 4H, Ar), 5.71 (d, J = 7.7 Hz, 1H, H-5), 5.60 (d, J = 6.5 Hz, 1H, H-1’), 4.61 – 4.49 (m,
1H, H-4’), 4.31 (m, 2H, H-3’, H-2’), 3.80 (s, 6H, OCH3), 3.54 – 3.34 (m, 4H,H-5’,
SeCH2CH2CN), 3.01 (m, 2H, SeCH2CH2CN), 2.91 (s, 1H, OH), 0.94 (s, 9H, SiCMe3), 0.09 (d,
6H, SiMe2); 13C NMR (CDCl3) δ: 167.70 (C-4), 159.04 (C-2), 158.51 (Ar), 144.17 (Ar), 139.19
(C-6), 134.91 (Ar), 134.74 (Ar), 130.26 (Ar), 130.17 (Ar), 128.30 (Ar), 128.11 (Ar), 127.58 (Ar),
118.78 (CN), 113.58 (Ar), 110.61 (C-5), 93.13 (C-1’), 87.82 (C-Ar3), 85.39 (C-4’), 77.27 (C-2’),
72.40 (C-3’), 63.82 (C-5’), 55.44 (OCH3), 25.84 (SiCMe3), 24.06 (SeCH2CH2CN), 18.89
(SeCH2CH2CN), 18.14 (SiCMe3), -4.56 (SiCH3)., -4.91 (SiCH3). HRMS (ESI-TOF) [M+H+]+ =
778.2464 (calc. 778.2427). Chemical Formula: C39H48N3O7SeSi. 10b: 1H NMR (CDCl3) δ: 8.09
(d, J = 7.7 Hz, 1H, H-6), 7.32 (m, 9H, Ar), 6.88 (m, 4H, Ar), 5.75 (d, J = 7.7 Hz, 1H, H-5), 5.65
(d, J = 3.7 Hz, 1H, H-1’), 4.46 (m, 1H, H-2’), 4.21 (dd, J = 9.3, 5.1 Hz, 1H, H-4’), 4.18 – 4.08
(m, 1H, H-3’), 3.83 (s, 6H, OCH3), 3.70 (m, 1H, H-5’), 3.55 (m, 1H, H-5’), 3.41 (m, 2H,
SeCH2CH2CN), 3.22 (d, J = 5.5 Hz, 1H, OH), 3.08 (m, 2H, SeCH2CH2CN), 0.90 (s, 9H,
SiCMe3), 0.11 (d, 6H, SiMe2). 13C NMR (CDCl3) δ: 167.90 (C-4), 159.05 (C-2), 157.82 (Ar),
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143.99 (Ar), 138.96 (C-6), 135.02 (Ar), 134.89 (Ar), 130.35 (Ar), 130.34 (Ar), 128.37 (Ar),
128.29 (Ar), 127.58 (Ar), 118.95 (CN), 113.56 (Ar), 113.53 (Ar), 110.49 (C-5), 93.84 (C-1’),
87.57 (C-Ar3), 84.72 (C-4’), 76.17 (C-2’), 71.05 (C-3’), 61.71 (C-5’), 55.48 (OCH3), 25.82
(SiCMe3), 24.12 (SeCH2CH2CN), 18.92 (SeCH2CH2CN), 18.17 (SiCMe3), -4.59 (SiCH3), -4.60
(SiCH3). HRMS (ESI-TOF) [M+H+]+ = 778.2401 (calc. 778.2427). Chemical Formula:
C39H48N3O7SeSi.
2.2.1.8 Synthesis of compound 11
1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,N-diisopropylamino)
phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2-cyanoethylselanyluridine
(Compound 11).
Diisopropylethylamine

(15.5

mg,

0.12

mmol)

and

2-cyanoethyl N,N-

diisopropylchlorophosphoramidite (26 mg, 0.11 mmol) were added to a solution of 10a (100 mg,
0.10 mmol) in dry dichloromethane (5 mL) at room temperature under nitrogen gas. The mixture
was monitored by TLC (15% ethyl acetate in dichloromethane). When the reaction was
completed in 4 hrs, rapid Al2O3 column chromatography (dichloromethane as the eluent) was
performed to remove the organic salts. The solvent was then evaporated under reduced pressure
and the residue was dissolved in 0.5 mL dichloromethane and precipitated in dry hexane under
vigorous stirring. The precipitate was collected by filtration, dried under reduced pressure and
directly used for solid phase synthesis. 1H NMR (CDCl3) δ: 7.95 (d, J = 7.7 Hz, 1H, H-6), 7.30
(m, 9H, Ar), 6.84 (m,4H, Ar), 5.82 (d, J = 7.6 Hz, 1H, H-1’), 5.63 (d, J = 7.7 Hz, 1H, H-5), 4.68
– 4.43 (m, 1H, H-4’), 4.43 – 4.29 (m, 1H, ), 4.24 (s, 1H), 3.98 (dd, J = 15.6, 8.4 Hz, 2H), 3.80 (s,
6H, OCH3), 3.63 (dd, J = 19.8, 7.3 Hz, 4H), 3.42 (dd, J = 19.3, 8.7 Hz, 5H), 3.01 (s, 2H), 2.70
(d, J = 5.8 Hz, 2H), 1.20 (d, J = 6.7 Hz, 18H), 1.08 (d, J = 6.5 Hz, 6H), 0.92 (s, 13H), 0.14 – 0.02
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(m, 9H); 13C NMR (CDCl3) δ: 167.83 (C-4), 159.04 (C-2), 158.71 (Ar), 144.16 (Ar), 139.02
(Ar), 134.96 (Ar), 134.74 (Ar), 130.21 (Ar), 130.14 (Ar), 128.38 (Ar), 128.04 (Ar), 127.58 (Ar),
118.86 (SeCH2CH2CN), 117.75 (OCH2CH2CN), 113.67 (Ar), 110.69 (C-5), 92.50 (C-1’) , 87.92
(C-Ar3), 85.43 (C-4’), 77.15 (C-2’), 72.81 (C-3’), 63.72 (C-5’), 59.39 (OCH2CH2CN), 55.48
(OCH3), 43.22-43.10 (NCMe2), 29.90 (OCH2CH2CN), 26.12-25.97 (NCMe2), 24.85 (SiCMe3),
24.02 (SeCH2CH2CN), 18.94 (SeCH2CH2CN), 18.37 (SiCMe3),-4.35 (SiCH3), -4.56 (SiCH3); 31P
NMR (CDCl3) δ: 148.81, 152.30. HRMS (ESI-TOF) [M+H+]+ = 978.3528 (calc. 978.3505).
Chemical Formula: C48H65N5O8PSeSi.
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2.2.2

Solid phase synthesis of the 2-Se-functionalized RNAs

Figure 2.2.1. Oligonucleotide solid phase synthesis cycle.
ABI3400 DNA/RNA Synthesizer was used for all the RNA oligonucleotides synthesis
(1.0 µmol scale). All the non-modified nucleoside phosphoramidite reagents used were ultramild (Glen Research). The synthetic cycle is a stepwise addition of nucleoside phosphoramidite
to the 5’ side of the nucleotide chain. It starts from detritylation of 5’-DMTr of the solid support
bounded oligonucleotide to free the hydroxyl group. Then the nucleoside phosphoramidite is
delivered to couple with the solid support bounded oligonucleotide in a solution of azole catalyst.
After coupling, the unreacted 5’-OH group is blocked with a capping mixture to prevent further
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elongation reactions. To stabilize the phosphite trimester linkage, the oxidation step is carried out
to transform it to a pentavalent phosphate with iodine, and then the solid support bounded
oligonucleotide ready for the new addition of next nucleobase (Figure 2.2.1).
RNA oligonucleotides were synthesized in DMTr-on form, cleaved from the beads and
deprotected by the treatment of 0.05 M K2CO3 methanol solution for 10 hours at room
temperature. After evaporating the solution to dryness, the 2’-TBDMS deprotection was
performed in TBAF (0.5 mL, 1 M) for 14 hours at room temperature. Then the RNAs were
treated with 1 M Tris-HCl buffer (0.5 mL, pH 7.5) for 5 min, followed by concentrating to 0.5
mL and desalting using G-25 Sephadex column. The 5’-DMTr deprotection was then performed
using Glen-Pek RNA column, followed by desalting using Sep-Pak Vas column.
2.2.3

pH titration curve of 2-selenouridine

Figure 2.2.2. Plot of wavelength (nm) versus pH for 2-selenouridine nucleoside.
2-Selenouridine was prepared through detritylation of 1-(5’-O-4,4’-dimethoxytrityl-b-D-
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ribofuranosyl)-2-selenour idine (8) by acid treatment. The 2-selenouridine solutions were
adjusted to desired pH values in the buffer of 50 mM Na2HPO4 at room temperature. The UV–
Vis spectra were recorded every 0.1 pH unit between pH 6–8 and every 0.2-0.5 pH unit between
pH 4–6 and pH 8–10. The pH of each solution was measured before and after its UV–Vis
spectrum collection and the error was within ±0.02 pH unit. The titration data was plotted and
shown in Figure 2.2.2.
2.2.4

HPLC analysis and purification

Table 2.2.1. MALDI-TOF MS of 2-Se-U RNAs
The RNA oligonucleotides were analyzed and purified by reversed-phase high
performance liquid chromatography (RP-HPLC), flow rate 6 mL/min [Buffer A: 20 mM
triethylammonium acetate (TEAAc, pH 7.1) in water; buffer B: 20 mM TEAAc (pH 7.1) in 50%
acetonitrile]. The HPLC analysis was performed with a linear gradient from buffer A to 100%
buffer B in 20 min. Native RNAs were purchased from Integrated DNA Technologies. The
concentrations of the native, S- and Se-modified RNAs were adjusted to 1.0 mM in water. The
S- and Se-RNA samples were characterized by MALDI-TOF MS (Table 2.2.1) and HPLC
(Figure 2.2.3).

23

Figure 2.2.3. HPLC analysis and purification of 2-S-U and 2-Se-U Modified RNAs.
(A) The HPLC analysis profile of crude DMTr-on Se-RNA (5’-rAUCACCSeUCCUUA-3’) after
cleavage from solid support and deprotection steps. The DMTr-on Se-RNA retention time was
12.2 min. (B) The HPLC analysis profile of pure DMTr-off Se-RNA (5’-rAUCACCSeUCCUUA3’) with same gradient and buffer. The DMTr-off Se-RNA retention time was 7.1 min. (C) The
HPLC analysis profile of pure DMTr-off Native-RNA (5’-rAUCACCUCCUUA-3’). The DMTroff Native-RNA retention time was 10.0 min. (D) The HPLC analysis profile of pure DMTr-off
S-RNA (5’-rAUCACCSUCCUUA-3’) with same gradient and buffer. The DMTr-off S-RNA
retention time was 10.4 min. Samples were eluted with a linear gradient from buffer A (20 mM
triethylammonium acetate, pH 7.1) to 70% buffer B (50% acetonitrile, 20 mM
triethylammonium acetate, pH 7.1) in 10 min, to 100% buffer B in 12 min and continuous 100%
buffer B to 20 min.
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2.2.5

Thermodenaturization of duplex RNAs

Table 2.2.2. Melting temperatures (Tm) of the native, S- and Se-modified RNA duplexes.
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Table 2.2.3. Melting temperatures of native and 2-Se-U RNA modified duplexes (5’rAAUGCUGCACUG -3’).
ΔTm1 refers to the Tm difference between the native U/A pair and the other mis-pairs (U/G, U/C
and U/U), and ΔTm2 refers to the Tm difference between the SeU/A pair and the other modified
mis-pairs (SeU/G, SeU/C and SeU/U).
UV-melting temperatures (Tm) of the native, S- and Se- modified duplexes with match
and mismatch sequences are shown in Table 2.2.2, Table 2.2.3 and Figure 2.2.6. Tm of the SeRNA duplex containing the SeU/A Watson-Crick pair was 2.4 or 3.0 oC higher than those of the
corresponding duplexes containing native U/A pair (Table 2.2.2, Figure 2.2.6). Comparing with
native U/G, the SeU/G pair is approximately 4 oC less stable than the native formation. While the
Se

U/C mis-pair is slightly less stable than the U/G pair, suggesting that SeU discourages the SeU/G

pair native U/C mis-pair, the SeU/U mis-pair is more stable than the native U/U mis-pair. The
higher stability may be attributed to the higher acidity of the imino group (3-NH) of SeU [pKa =
7.29 ± 0.02, Figure 2.2.2, compared to that of the native uridine (pKa = 9.18 ± 0.02)45], which
may promote U/U inter- action via hydrogen bond. In addition, considering a selenium atom is
0.43 Å larger in atomic radius than an oxygen atom, the 2-Se atom may strengthen the stacking
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interaction between SeU and its 3’-nucleobase (Figure 2.2.4).

Figure 2.2.4. Local structures of the native RNA and SeU-containing RNA r[5’GUAUA(SeU)AC-3’]2 with a resolution of 2.3 Å.
The 2-position atom (oxygen or selenium) of U6 stacks with A7. (A) The native 5’-U6-A7-3’
local structure; (B) the native 5’- SeU6-A7-3’ local structure. A selenium atom is 0.43 Å larger in
atomic radius than an oxygen atom.
When directly comparing the Watson-Crick base pairs (U/A and SeU/A) with their own
corresponding mis-pairs, it is clear that SeU/A pair has the balanced discrimination against all
mis-pairs, with the Tm differences of SeU/G (7.3 oC in Figure 2.2.5 and 11.0 oC in Table 2.2.3),
Se

U/C (15.5 oC), and

Se

U/U (8.5 oC). On the other hand, the native U/A pair has poor

discrimination against U/G wobble pair (the Tm differences: 0.3 oC in Figure 2.2.5 and 4.7 oC in
Table 2.2.3), while maintaining fine discrimination against U/C (12.2 oC) and U/U (14 oC) pairs.
Therefore, in general,

Se

U/A has higher base pair fidelity than the native U/A pair. When

comparing the SeU/A with the corresponding SU/A pair, the same statement is also true (Figure
2.2.5). Furthermore, the Tm difference (8.5 oC) of

Se

U/A and

Se

U/U is bigger than the Tm

difference (5.8 oC) of SU/A and SU/U, thus the SeU/A can better discriminate against SeU/U mispair than the SU/A against SU/U mis-pair. In general, SeU/A can better discriminate against all
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corresponding mis-pairs than SU/A, thereby SeU/A offering higher base pair fidelity than SU/A.

Figure 2.2.5. Differences of melting temperatures (Tm) of the native, S- and Se-modified U/A
pairs and their corresponding mis-pairs.
O (white bar) refers to the Tm difference between the native U/A pair and the other mis-pairs
(U/G, U/C and U/U); S (grey bar) refers to the Tm difference between the SU/A pair and the
other modified mis-pairs (SU/G, SU/C and SU/U); Se (black bar) refers to the Tm difference
between the SeU/A pair and the other modified mis-pairs (SeU/G, SeU/C and SeU/U).
As hypothesized, the 2-Se-functionality on uridine can indeed largely increase the base
pairing specificity of RNA by discriminating against U/G wobble pairing. The Tm differences
between the native U/A pair and U/G wobble pair were relatively small (4.7 oC in Figure 2 and
0.3 oC in Figure 2.2.6). The small Tm differences indicate possible changes between U/A and
U/G pairs without a significant decrease in duplex stability. This is consistent with the ubiquitous
presence of U/G wobble pair in RNAs, which diversifies the structure and function of RNAs,
especially non-coding RNAs. Such small thermostability difference between native U/A pair and
U/G wobble pair has been previously observed in the literature.29a Interestingly, the Tm
differences between the SeU/A and SeU/G pairs were significant, such as 7.3 oC (vs 0.3 oC in the
native) in Figure 2 and 11 oC (vs 4.7 oC in the native) in Table 2.2.3. The SeU modification in
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RNA duplexes directly decreases the thermal stability of the U/G wobble pair by 4.0 oC (Table
2.2.2) and 3.9 oC (Table 2.2.3). This experimental observation reveals that the U/G wobble pair
is greatly discriminated by incorporating a selenium atom to the 2 position of uridine. The strong
discrimination against U/G pair is mainly attributed to the selenium disruption of the hydrogen
bond formed by the 2-oxygen (Figure 2.1.1) and to the steric effect of the bulky selenium atom at
the 2-position. Clearly, our results indicate that the 2-Se-modification on uridine significantly
increases the high specificity of the U/A base pair.
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Figure 2.2.6. Normalized UV-melting curves of RNA duplexes.
(A) Native RNA (5’-rAUCACCUCCUUA-3’) paired with matched and mismatched strands; (B)
Modified RNA (5’-rAUCACCSeUCCUUA-3’) with matched and mismatched strands. (C) Native
RNA (5'-rAAUGCUGCACUG-3') paired with matched and mismatched strands; (D) Modified
RNA (5'-rAAUGCSeUGCACUG-3') with matched and mismatched strands.
2.2.6

Crystallization and data collection of Se-RNA
Perfluoropolyether was used as a cryoprotectant during the crystal mounting, and data

collection was taken under the liquid nitrogen stream at 99°K. The Se-RNA crystal data were
collected at beam line X12B and X12C in NSLS of Brookhaven National Laboratory. A number
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of crystals were screened to identify the one with strong anomalous scattering at the K-edge
absorption of selenium. The distance of the detector to the crystals was set to 150 mm. The
wavelength of 0.9795 Å was chosen for selenium SAD phasing. The crystals were exposed for
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did not crystallize in 3–4 weeks under the same conditions. Moreover, the Se-RNA crystals
could form in broader buffer conditions (12 out of 24 conditions in Hampton buffers) than the
corresponding native (2 out of 24 conditions). This observation of faster crystal growth of the SeRNA is consistent with the Se-facilitated duplex stability. As shown in Figure 2.2.7A, there are
seven self-complementary RNA molecules in a unit cell, and the overall shape of the duplexes is
almost linear (approximately 8o inclination to the screw axes). Although this assembling pattern
results in the discontinued backbones and grooves, the duplexes stack on top of each other in a
head-to-tail fashion, and a peudo-fiber is formed. The data collection and structure refinement
statistics are summarized in Table 2.2.4.
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Figure 2.2.7. Global and local structures of the SeU-containing RNA r[5’-GUAUA(SeU)AC-3’]2
with a resolution of 2.3 Å.
(A) The overall structure of duplex. (B) The superimpose comparison of one SeU-RNA duplex
(red; PDB ID: 3S49) with its native counterpart [5’-r(GUAUAUA)-dC-3’]2 (cyan; PDB ID:
246D) with a RMSD value 0.55. The two red balls represent the selenium atoms. (C) The
experimental electron density of SeU6/A11 base pair with s=1.0. (D) The superimpose
comparison of the local base pair SeU6/A11 (red) and the native U6/A11 (cyan). The numbers
indicate the distance between the corresponding atoms.

Since 2-exo-oxygen of uridine is not involved in the hydrogen bond interactions of U/A
pairing, it’s expected that the U/A pair will accommodate the larger selenium atom at this
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position (Figure 2.1.1 and Figure 2.2.7C). The Se-modification also leads to the acidity increase
of the 3-imino group (NH) in the 2-Se-uridine, which strengthens the hydrogen bond between N3
of U6 and N1 of A11. Indeed, after the selenium modification, the U/A hydrogen bond length
between N3 of U6 and N1 of A11 is shortened from the native distance (3 Å) to the Se-modified
distance (2.81 Å). Moreover, after the Se-modification (Figure 2.2.7D), the U/A hydrogen bond
length between O4 of U6 and N6 of A11 decreases by 0.47 Å from the native distance (3.39 Å)
to the Se-modified distance (2.92 Å). The shortened H-bond lengths indicate stronger H-bonds,
which may explain the increase of duplex stability after the Se-modification. On the contrary, the
distance between Se2 of U6 and C2 of A11 in the Se-modified duplex is slightly increased. This
distance increase is likely due to a steric effect. This steric clash at the position 2 of the Seuridine can be a driving force to increase SeU/A pair specificity. Consistent with our biophysical
study, our structure study has indicated that the selenium bulkiness at the uridine 2-postion
discourages the U/G wobble pairing. Moreover, due to the electronic effect of a selenium atom,
the inability of a Se atom to form a stable hydrogen bond is another main factor responsible for
the discrimination against U/G wobble pair.
2.3
2.3.1

Study of U/G Wobble Pair
U/G wobble pair experimental design and crystallization
Base on our biophysical studies, we were able to confirm the modified 2-Se-uridine is

able to maintain the U/A base pair stability meanwhile destabilizing U/G wobble pair. Our 2.3Å
resolution crystal structure of SeU/A RNA base pair further prove that the selenium atom did not
disrupt the overall structure of the RNA but slightly shorten the local hydrogen bonding of the
Se

U/A pair and enhance the stacking of the SeU/A pair with neighboring base pairs. To further

explore the SeUG wobble pair in the real structure and for better comparison, we choose the
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same self-complimentary sequence but switch the A to a G against SeU for the study. The newly
designed sequence (5’-GUGUAUAC-3’) should form two UG wobble pairs in the eight bases
double helix region (Figure 2.3.1). Both the native RNA sequence (5’-GUGUAUAC-3’) and Semodified RNA sequence (5’-GUGUASeUAC-3’) were synthesized through solid phase synthesis
and purified by HPLC for crystal growth. The integrity of the Se-modified RNA is approved by
mass spec analysis, Chemical Formula: C76H95N29O54P7Se, [M+H+]+: 2574.3, observed 2574.4
(Figure 2.3.1).

5'- G U A U A U A C -3'
3'- C A U A U A U G -5'

5'- G U G U A U A C -3'
3'- C A U A U G U G -5'

Figure 2.3.1. Design of RNA duplexes.
Left: 5’-GUAUAUAC-3’ with all Watson-crick base pairs. Right: 5’-GUGUAUAC-3’ with two
UG wobble pairs. Base pairs of interests were labeled in red.
The purified RNAs was adjusted to 1 mM concentration and was annealed with itself by
heating up to 80oC and then was slowly cool to room temperature. The 24 screening buffers were
from Hampton Research Nucleic Acid Mini screen kit (APPENDICES). The RNA was mix with
screening buffer at 1:1 ratio hanging against 35% MPD (2-methyl-2,4-pentanediol). Among 24
conditions, the native sequence (5’-GUGUAUAC-3’) was crystallized in four conditions (No.
10, 15, 17, 19) with in 24 hours while Se-modified sequence (5’-GUGUASeUAC-3’) was
crystallized in thirteen conditions (No. 2, 3, 4, 6, 8, 10, 11, 12, 15, 17, 19, 20, 21) with in 24
hours. The native crystals perform rod-shaped while the Se-modified crystals appear long
needle-shaped (Figure 2.3.2).
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Figure 2.3.2. Crystal growth comparison with native and Se-modified RNA in 24 hours.
Left: Native RNA crystal (5’-GUGUAUAC-3’) with four buffer conditions. Right: Se-modified
RNA (5’-GUGUASeUAC-3’) with thirteen buffer conditions.

2.3.2

Crystal structure of Native 5’-GUGUAUAC-3’ RNA

Figure 2.3.3. Global and local structures of native RNA 5’-GUGUAUAC-3’
A. Global structures of native RNA 5’-GUGUAUAC-3’; B. Wobble pairs G3/U14 and U6/G11
with strontium ion at C4 position of uridine.
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The native 5’-GUGUAUAC-3’ structure was determined at 2.2 Å resolution with molecular
replacement (PDB ID: 1JAB), the data was collected at beam line BL8.2.2 of the ALS
(Advanced Light Source) at the Lawrence Berkeley National Laboratory. The structure of the Aform RNA shows a perfect 8-base duplex with two UG wobble pairs buried in the middle. The
structure was deposited in PDB (1JAB). From the structure, the two UG pairs (G3U14 and
U6G11) were both stabilized by strontium ions at C-4 position carbonyl of uridine (Figure
2.3.3). The UG wobble pairs were also compared with U/A Watson-crick base pairs by global
structures superimpose of the both RNA sequences (Figure 2.3.4). The structures were almost
identical and no significant perturbation observed.

A.

B.

C.

Figure 2.3.4. Native RNA 5’-GUGUAUAC-3’ and 5’-GUAUAUAC-3’ structures.
A. Native RNA structure (5’-GUAUAUAC-3’) PDB: 246D with all watson-crick base pairs; B.
Native RNA structure (5’-GUGUAUAC-3’) PDB: 1JAB with two wobble base pairs; C.
Superimposed of 1JAB and 246D structures.
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2.3.3

Crystal structure of 5’-GUGUASeUAC-3’ RNA
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Figure 2.3.5. Hydrogen bonding pattern of 2SeU/A base pair and 2SeUG wobble pair.
The actual structure of the Se-modified was not as expect as the native structure (5’GUGUAUAC-3’). However, the selenium atom at C2 of uridine generates a great hindrance
when pairing with G to form a wobble pair (Figure 2.3.5), thus RNA refuses to form an 8-based
double-strand helix. Instead, each RNA duplex is formed with 6 base pairs and a two nucleotides
overhang on each end (Figure 2.3.6). In this particular situation, the Se-modified uridine forms
Se

U/A watson-crick base pair to avoid the SeUG wobble pair but rather to form two native UG

wobble pair at each of the overhang end with neighboring duplex, which made it altogether two
UG wobble pairs and two SeU/A watson-crick base pairs in each 8-based unit. This observation
has strongly confirmed our previous hypothesis again that when the uridines at wobble base pair
positions are replaced by SeU, the UG wobble pair was strongly discouraged.

!"!"!"!"

!"!"!"!"
!"!"!"!"

Figure 2.3.6. The SeU-RNA (5’-GUGUASeUAC-3’) crystal structure formation.

!"!"!"!"
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The 5’-GUGUASeUAC-3’ structure was determined at 1.5 Å resolution with molecular
replacement (PDB ID: 1JAH). The data was collected at beam line BL8.2.2 of the ALS
(Advanced Light Source) at the Lawrence Berkeley National Laboratory. This high-resolution
structure offers the most detailed

2Se

U containing RNA structure to date. In each duplex pair,

there are two selenium atoms in the minor groove of A-form RNA, with distance of 3.69 Å, 3.93
Å, and 3.93 Å respectively (Figure 2.3.7). The structure indicated a three RNA duplex bundle in
the asymmetric unit. The intermolecular contacts of the overhand UG interactions between
duplexes probably drive the packing of crystals.

Figure 2.3.7. Structure of 5’-GUGUA2SeUAC-3’ RNA with electron density map.
A. Three duplexes bundle in asymmetric unit; B. RNA duplex with two nucleotides overhang on
each end; C. 2SeU/A and U/A base pairs superimposed with each other and the measurements of
the hydrogen bonds.
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3

2-SELENOURIDINE TRIPHOSPHATE SYNTHESIS AND SE-RNA
TRANSCRIPTION

3.1

Introduction
The text of this work has been published as “2-Selenouridine Triphosphate Synthesis and

Se-RNA Transcription”, RNA, 2013, 19, 1309-1314. I would like to acknowledge Dr. Sibo
Jiang, Dr. Julianne Caton-Williams, Dr. Hehua Liu and Dr. Zhen Huang for their intellectual
contribution as co-authors.
3.1.1

RNA modification
RNA is involved in numerous biological processes, such as genetic storage, transcription,

translation, and regulation.2a, 27b Moreover, RNA can fold into well-defined three-dimensional
structures to interact with proteins and catalyze biochemical reactions.1b, 2b The appreciation for
the uniqueness of RNAs, especially non- coding RNAs for their structure and function
diversities, has increased extensively in the past decade. However, the functional understanding
of these complicated macromolecules is often limited. The functional understanding of many
natural modifications of the RNAs is even less. Thus, studying RNA natural modifications has
become a very active research area in order to better understand biophysical and chemical
properties of RNAs (such as tRNA and rRNA). So far, >100 RNA modifications have been
discovered in nature,5 and many of them are frequently dis- covered in tRNA. 2-Selenouridine (2Se

U or

Se

U) is one of naturally occurring nucleosides and exists at the wobble position of the

anticodon loop in various bacterial tRNAs (Escherichia coli, Methanococcus vannielii,
Clostridium sticklandii, etc.).5, 18 This Se-modification might play a critical role in the mRNA
decoding process. It was hypothesized that the 2-Se-modification may enhance the accuracy and
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efficiency of protein translation.9a, 48
3.1.2

Selenium in X-ray crystallography
Moreover, another advantage of selenium modification in nucleic acid research is its

assistance in addressing phase issue in X-ray crystallography via multiwavelength anomalous
dispersion (MAD) or single-wavelength anomalous dispersion (SAD). Heavy atoms, such as
selenium (Se) and bromine (Br), are suitable as anomalous scattering centers, which have been
extensively applied in protein and nucleic acid crystallography. Encouraged by the successful
selenium-assisted MAD phasing,49 we have pioneered and established nucleic acid X-ray
crystallography with selenium derivatization.9b, 11, 50 Among the synthesized Se-derivatives, 2selenouridine is stable and the only one found in nature so far. Furthermore, the single oxygen
atom substitution with selenium at the exo-2 position doesn’t interfere with the hydrogen
bonding in the Watson-Crick U/A base pair, thereby preserving the base-pairing function and
structure.9a Therefore, the 2-selenouridine synthesis and its incorporation into RNAs may largely
facilitate both structure and function investigations.
3.1.3

Methods for Se-RNA synthesis
Generally, there are two strategies to synthesize the Se-derivatized RNAs: solid-phase

synthesis, and transcription. The first method offers the site-specific incorporation of the Senucleoside. However, it is limited to relatively short RNAs (up to 50 nt) for large-scale synthesis.
In addition, it requires multiple steps in deprotection and purification. The 2-selenouridine
chemical incorporation into RNAs has been achieved via solid-phase synthesis.9a Our biophysical
studies have shown that the 2-Se-modification discriminates against a U/G mismatch (wobble
pair), while pre- serving the native U/A pair. This result indicates that

Se

U can largely improve
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the RNA base-pairing specificity and the RNA–RNA interaction fidelity. This result has
encouraged us to incorporate the Se-modification into RNA by in vitro transcription, in order to
further investigate the function and structure of the

Se

U-RNAs, such as the

Se

U-containing

tRNAs. This enzymatic method can allow synthesis of longer RNAs (>50 nt) in a large quantity
(multiple milligrams). Multiple selenium atoms can also be conveniently incorporated into RNA
under the mild conditions. As a matter of fact, the transcription strategy with T7 RNA
polymerase is favored by most molecular and structural biologists. Herein, we report the first
synthesis of 2-selenouridine triphosphate (SeUTP) and the enzymatic incorporation of SeUTP into
noncoding RNAs. The active and mutant hammerhead ribozymes (Figure 3.1.1) were
successfully transcribed and examined with
is active, suggesting that the

Se

Se

UTP. The transcribed

Se

U-hammerhead ribozyme

U- RNAs are useful in both function and structure studies of

noncoding RNAs.

Figure 3.1.1. Hammerhead ribozymes.
(A) Secondary structure of the self-cleaving SeU-hammerhead ribozymes, including the wild type
(WHR) and crippled mutant (MHR). The mutant and cleavage sites are indicated by arrows.
Highly conserved bases are highlighted in gray. (B) Secondary structure of the non-self- cleaving
Se
U-hammerhead ribozyme and its 5’-32P-labeled RNA substrate.
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3.2
3.2.1

General Experiment Section
2-Se-uridine triphosphate synthesis
In order to minimize by-product formation, the Se-nucleobase modifications are normally

protected during chemical synthesis.9a,

20-21, 51

Since the 2-seleno-modification on uridine is

naturally occurring, we decided to directly explore its compatibility with chemical synthesis. We
were pleasantly surprised that 2-seleno-uridine, without protection, can be directly converted to
the corresponding triphosphate. Thus, the synthesis (Scheme 3.2.1) of

Se

UTP (3) started from

deprotection of the 5’-DMTr group of the Se-uridine derivative 19a under an acidic condition.
Then, 2-Se-uridine (2) was converted to SeUTP (3) via a one-pot synthesis: sequential treatments
with phosphorus oxychloride (POCl3), pyrophosphate, and bicarbonate.51a, 52

Scheme 3.2.1. Chemical synthesis of SeUTP and transcription of SeU-containing RNA.
Reagents and conditions: (a) 4% trifluoroacetic acid; (b) POCl3, Me3PO4; (tri-n-butyl)amine,
pyrophosphate, N, N-dimethyl-formamide; the H2O hydrolysis; (c) RNA transcription.
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3.2.1.1 Synthesis of 2-Se-uridine
Trifluoroacetic acid (11 mg) was added to 5’-DMTr-2-Se-uridine (Scheme 3.2.1, step 1,
305 mg, 0.5 mmol)9a (Sun et al. 2012) in dichloromethane (5 mL). The solution was heated at
40°C for 30 min, followed by adding methanol (0.2 mL). The reaction was stirred vigorously for
another 1 h to obtain a light yellow precipitate product (Scheme 3.2.1, step 2). The precipitate
was recovered by centrifugation or filtration; the yield of step 2 was almost quantitative.
3.2.1.2 Synthesis of 2-Se-uridine triphosphate
2-Se-uridine (Scheme 3.2.1, step 2, 20 mg) was weighed and dried in a flask under high
vacuum overnight, followed by injecting trimethyl phosphate (0.4 mL) to dissolve it and then
stirring the flask in an ice bath. A solution of proton-sponge (55 mg, 2 eq) in trimethyl phosphate
(0.3 mL) was injected into the solution of step 2 at 0°C. After 3 min stirring, phosphorus
oxychloride (POCl3; 9 μL, 1.5 eq) diluted in trimethyl phosphate (90 μL) was dropwise added
into the solution of step 2 at 0°C. The reaction was completed in 1.5 h (monitored on TLC).
Tributylammonium pyrophosphate (64 mg, 2 eq., dissolved in 0.2 mL tributylamine and 0.4 mL
DMF) was then quickly injected into the reaction. After vigorously stirring for 5 min, the
reaction was quenched with triethylammonium bicarbonate (1 M, 3 mL) and stirred for another 1
h at the room temperature to obtain compound 3. To the reaction solution, NaCl (3 M NaCl, 0.5
mL) was added, followed by adding ethanol (14.5 mL) and freezing the suspension at −80°C for
1 h to precipitate the crude product. Compound 3 was recovered by centrifugation for 25 min at
14,000 rpm. The pellet was redissolved in water and analyzed by HPLC. SeUTP (step 3) was
purified by HPLC. The identity of SeUTP as a triethylammonium salt was confirmed by NMR
(1H-, 13C-, and 31P-NMR) and mass analyses. 1H-NMR (400 MHz; D2O) δ: 8.22 (d, J = 8.1 Hz,
1H, H-6), 6.79 (d, J = 3.0 Hz, 1H, H-1’), 6.38 (d, J = 8.1 Hz, 1H, H-5), 4.54–4.33 (m, 5H, H-2’,
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3’, 4’, 5’), 3.21 (d, J = 7.3 Hz, CH2 of triethylammonium), 1.28 (t, J = 7.3 Hz, CH3 of
triethylammonium). 13C-NMR (100 MHz; D2O) δ: 174.7 (s, C-4), 161.7 (s, C-2), 140.9 (s, C-6),
107.6 (s, C-5), 94.6 (s, C-1’), 82.2 (d, J = 9.1 Hz, C-4’), 74.0 (s, C-2’), 67.3 (s, C-3’), 62.9 (d, J =
5.1 Hz, C-5’), 45.6 (s, CH2 of triethylammonium), 7.2 (s, CH3 of triethylammonium). 31P-NMR
(162 MHz; D2O) δ: −7.4 (d, J = 19.7 Hz, α-P), −11.3 (d, J = 19.6 Hz, γ-P), −22.1 (t, J = 19.6 Hz,
β-P). HRMS (ESI-TOF) [M-H+]- = 546.8812 (calc. 546.8829)
3.2.1.3 Purification and analysis of 2-Se-uridine triphosphate
The maximal UV absorbance of native uridine triphosphate is 260 nm, while that of the
Se

U-triphosphate is 307 nm. In the HPLC analysis, both the native and selenium-modified UTPs

were monitored under two wavelengths (260 and 307 nm). The synthesized SeUTP was purified
by HPLC (Ultimate XB-C18, 250 mm×21.2 mm, 10 μm) with a gradient of 100% buffer A (20
mM triethylammonium acetate in water) to 25% buffer B (20 mM triethylammonium acetate in
50% acetonitrile and 50% water) for 20 min. The HPLC analysis was performed (Ultimate XBC18, 250 mm × 4.6 mm, 5 μm) with a gradient from 100% buffer A (20 mM triethylammonium
acetate in water) to 40% buffer B (20 mM triethylammonium acetate in 50% acetonitrile and
50% water) for 15 min. The HPLC and UV profiles are shown in Figure 3.2.1. The retention
times of the native UTP and SeUTP were 11.2 and 14.1 min, respectively.
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Figure 3.2.1. HPLC and UV analyses of SeUTP.
A) HPLC profiles: a) Native UTP monitored at 260 nm (retention time: 11.2 min); b) Native
UTP monitored at 307 nm; c) SeUTP monitored at 260 nm (retention time: 14.1 min); d) SeUTP
monitored at 307 nm (retention time: 14.1 min); e) co-injection of both native UTP and SeUTP
monitored at 260 nm (retention time: 11.2 min and 14.1 min); f) co-injection of both native UTP
and SeUTP monitored at 307 nm (retention time: 14.1 min). B) UV-spectrum of SeUTP (lmax= 307
nm).
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3.2.2

Transcription of RNAs
Transcription experiment was carried out following standard procedures from

manufacturer Epicentre (AmpliScribe™ T7-Flash™ Transcription Kit). ATP [α-32P] was use as
radioactive labeling material in this experiment. For each reaction (5 μL), final concentration of
0.5 mM NTP (A, U, G, C in the transcription of native RNAs and A,

Se

U, G, C in the

transcription of Se-modified RNAs), 50 ng/μL linearized DNA plasmid template, 10 mM DTT,
1×transcription buffer for T7 RNA polymerase and 0.5 μL of T7 RNA polymerase (10 U) were
added into reaction tube with RNase-free water to adjust total reaction volume to 5 μL. In
transcription efficiency (time-course) experiment, a gel loading dye (5 μL) with 100 mM EDTA
was used to terminate reaction at each time point with additional heating (75oC for 30 min). Later
the experimental result was visualized via denaturing urea PAGE gel (15%) and
autoradiography. Two templates practiced in transcription experiments were double-stranded
DNA prepared by PCR. The translated RNAs are mutant hammerhead ribozyme (MHHR) with
sequence

of

5’-

GGGAGCCCUGUCACCGGAUGUGCUUUCCGGUCUGAUGAGUCCGUGAGGACAAAAC
AGGGCUCCCGAAUU-3’ (Figure 3.1.1) and wild-type hammerhead ribozyme (WHHR) with
sequence

of

5’-

GGGAGCCCUGUCACCGGAUGUGCUUUCCGGUCUGAUGAGUCCGUGAGGACGAAAC
AGGGCUCCCGAAUU-3’ (Figure 3.1.1).53

3.2.2.1 Transcription with native NTPs

All native NTPs, the transcription buffer, and T7 RNA polymerase used in
our transcription experiments were purchased from Epicentre. The templates of the
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wild-type and mutant hammerhead ribozymes were from the linearized plasmids
(Lin et al. 2011a). The native RNAs were transcribed with the transcription protocol (final
concentration) in RNA polymerase buffer (40 mM Tris-HCl, 6 mM MgCl2, 2 mM spermidine,
pH 7.9), DTT (10 mM), ATP, UTP, CTP, and GTP (0.5 mM each NTP), DNA template (nonself-cleaving hammerhead ribozyme: 1 μM dsDNA template [55 nt]; self-cleaving hammerhead
ribozyme [mutant and wild-type]: 50 ng/μL linearized plasmid), T7 RNA polymerase (2
units/μL, Epicentre), and RNase-free water to adjust to the final volume (e.g., 20 μL). The
transcription reaction was incubated for 1 h at 37°C.
3.2.2.2 Transcription and analysis of Se-RNAs
The Se-RNAs were transcribed with the transcription protocol (final concentration) in
RNA polymerase buffer (40 mM Tris-HCl, 12 mM MgCl2, 2 mM spermidine, pH 7.5), DTT (10
mM), ATP,

Se

UTP, CTP, and GTP (0.5 mM each NTP), DNA template [non-self-cleaving

hammerhead ribozyme: 1 μM dsDNA template (55 nt); self-cleaving hammerhead ribozyme
(mutant and wild-type): 50 ng/μL linearized plasmid], T7 RNA polymerase (4 units/μL,
Epicentre), and RNase-free water to adjust to final volume (e.g., 20 μL). The transcription
reaction was incubated for 3 h at 37°C. To examine the

Se

UTP compatibility with RNA

polymerase in transcription, the linearized plasmid templates for the wild-type hammerheadribozyme (WHR) and the crippled mutant hammerhead-ribozyme (MHR) were used (Figure
3.1.1) for the

Se

U-RNA transcription. As expected,

Se

UTP was recognized by T7 RNA

polymerase (Figure 3.2.2A). Moreover, the mutant SeU-ribozyme (69-nt; containing 15 selenium
atoms) was pre- pared via RNA transcription, and the integrity of the SeU-ribozyme (SeU-MHR)
was confirmed by MS analysis (Figure 3.2.2C).

48

Figure 3.2.2. The SeU-ribozymetranscription with SeUTP and T7 RNA polymerase.
(A) The auto-radiography gel image of in vitro transcription; (left) transcription of the native
RNA (the crippled mutant hammerhead-ribozyme: MHR) with all native NTPs; the minor fastermoving band is the self-cleaved product (fragment); (right) transcription of the SeU-MHR with
Se
UTP and other native NTPs. (B) Optimized Se-RNA transcription (∼85% yield compared to
the corresponding native RNA transcription). Transcription conditions are listed in Table 3.2.1.
C) MALDI-TOF MS analysis of the SeU-MHR (molecular formula: C657H817N264O476P71Se15);
matrix: 3-hydroxypicolinic acid (3HPA, molecular formula: C6H5NO3); mass of SeU-MHR and
matrix observed: 23550.9 (calc. 23551.4).

3.2.2.3 Optimization of SeU-RNA transcription
To maximize the transcription yield, condition optimizations have been performed. The
linearized plasmid of the mutant hammerhead ribozyme (Figure 3.1.1) was used as the template,
which incorporates 15 SeUs into the ribozyme. The transcription buffers with various pH values
were first examined, since the acidity of the imino group (3-NH) of SeU is higher than that of the
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native U.9a The pH values of the transcription buffer (40 mM Tris base or sodium phosphate, 6
mM MgCl2, 2 mM spermidine, and 10 mM DTT) were adjusted. The Se-RNA transcription was
examined under eight pH values (pH 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5, and 9.0) and indicated that
pH 7.5 was optimal for the Se-RNA transcription (Figure 3.2.3). The pH of the standard
transcription buffer is 7.9.

Figure 3.2.3. Experimental results of transcription optimizations with SeUTP.
(A) Optimization of the transcription buffer pH (5.5–9.0). pH 7.5 is optimal for the Se-RNA
transcription, while the pH of the standard transcription buffer is 7.9. (B) Data analysis of the pH
optimization.
Mg2+ concentration in the transcription buffer was also examined by varying it from 4 to
12 mM. As the increased MgCl2 concentration yielded higher transcription yield (Figure 3.2.4A),
12 mM MgCl2 was chosen for the Se-RNA transcription. Other components, such as spermidine
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(from 2–8 mM) and

Se

UTP (from 0.5 to 1.5 mM), were also examined for the transcription

optimization. However, we found that increases of the concentrations of these components
slightly decreased the transcription yield (Figure 3.2.4B).
Table 3.2.1. Optimized conditions for the Se-RNA transcription
UTP
T7
pH
Mg2+
concentration
polymerase
Native
7.9
6 mM
0.5 mM
10 units
condition
Se-modified
7.5
12 mM
0.5 mM
20 units
condition

Transcription
time
1h
3h

Moreover, a higher quantity of T7 RNA polymerase can increase the Se-RNA
transcription yield (Figure 3.2.4C). Finally, after combining these optimized conditions (Table
3.2.1), we could increase the yield of the SeU-RNA transcription up to 85% of the corresponding
native RNA (Figure 3.2.2B), and these conditions have been used to transcribe various SeU-RNA.

Figure 3.2.4. Experimental results of transcription optimizations with SeUTP.
A). Optimization with increasing MgCl2 concentrations. Standard transcription buffer contains 6
mM MgCl2. B). Optimization with increasing spermidine concentrations. Standard transcription
buffer contains 2 mM spermidine. C). Optimization with T7 RNA polymerase quantity (10 to 40
unit/μL).
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3.2.3

Catalytic activity analysis of the Se-RNAs

3.2.3.1 Self-cleaving wild-type hammerhead ribozyme
To examine hammerhead ribozyme activity with regard of time, we use the wild-type
template to transcript both native and Se-modified ribozyme in a self-cleavage manner since the
wild-type template directs active ribozyme synthesis while the ribozyme cleaves itself
spontaneously (Figure 3.2.5A). The transcription reaction was carried out in standard T7 reaction
buffer (containing 6 mM MgCl2) and the result clearly indicated that under standard transcription
condition the native hammerhead ribozyme cleavage itself completely while Se-modified
ribozyme is quite active but the cleavage is not complete. Later, we examined the selenium
modified ribozyme activity in a transcription solution with increased MgCl2 concentration to 10
mM (ref). Under this condition, Se-modified ribozyme gives a complete and efficient activity
(Figure 3.2.5B).

Figure 3.2.5. Wild-type native and Se-modified ribozyme transcription with self-cleavage
activity during synthesis.
A) The experiment is carried out under standard transcription buffer condition (40 mM Tris-HCl,
6 mM MgCl2, 10 mM NaCl, 2 mM spermidine and 10 mM DTT) and a mutant native and Semodified ribozyme was used as comparison respectively. B) Wild-type selenium modified
ribozyme transcription with a standard transcription buffer of 10 mM MgCl2. A Se-modified
mutant ribozyme is used as comparison.
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3.2.3.2 Non-self-cleaving hammerhead ribozyme
The

non-self-cleaving

hammerhead

ribozyme

(5’-GGCA-ACCUGA

UGAGGCCGAAAGGCCGAAACGUACA-3’) (Figure 3.1.1) for the catalytic experiments was
transcribed following the standard procedures described above. The DNA template used for this
transcription

was

a

55-nt

dsDNA

(5’-

TGTACGTTTCGGCCTTTCGGCCTCATCAGGTTGCCTATAGTGAGTCGTATTACGC-3’
and its complementary sequence). After the transcription, the native and Se-modified ribozymes
were purified and adjusted to the same concentration (monitored by UV). The RNA substrate (20
nt, 5’-ACCUGUACGUCGUUGCCUAA-3’) (Figure 3.1.1) chemically synthesized by solidphase synthesis was kinased with γ-32P-ATP at the 5’ end for the ribozyme digestion. The
digestion was performed in the buffer (10 mM Tris-HCl, 10 mM MgCl2, pH 7.6) and with 5’-32Plabeled RNA substrate (final concentration: 50 μM) at 27° C. Aliquots (10 μL each) were taken
at the time intervals (0, 5, 10, 30, 90, and 150 min), and each was mixed with EDTA (5 μL, 50
mM) dissolved in a saturated urea solution (aqueous) to quench the digestion. The 5’-labeled
RNA substrate was digested to the 9-nt fragment and the 5’-32P-RNA fragment (11 nt). The 32Plabeled RNA allowed monitoring the substrate digestion via gel electrophoresis and
autoradiography. The time-course results of the ribozyme digestion are shown in Figure 3.2.6.

53

Figure 3.2.6. The catalytic activity of the Se-modified ribozyme.
(A) The time-course experiment of the 5’-32P-RNA substrate digested with the non-self-cleaving
native and Se-modified hammerhead ribozymes under the same conditions. The experiment was
carried out at room temperature, with 10 mM Mg2+, in the ribozyme buffer. (B) Time-course
experiment of (A) with different 5’-32P-RNA substrate concentration. (C) Plot of the SeUribozyme catalysis (dashed line) compared with the corresponding native (solid line). The
cleavages of the RNA substrate by the native and Se-modified ribozymes (y-axis) were
normalized via comparison to the substrate cleavage by the native ribozyme at 150 min (defined
as 1.0).
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3.2.4

Thermostability of the SeU-RNA
To examine the thermostability of the SeU-RNA, we designed a short Se-RNA (trimer: 5’-

USeUU-3’) for this study. This Se-RNA was chemically synthesized by solid-phase synthesis and
purified.9a We heated the Se-RNA continually at 70°C for a few hours and monitored it by HPLC
at both 260 and 307 nm, since the 2-selenium modification has a unique UV-absorption at 307
nm, while the native nucleotides absorb strongly at 260 nm. The HPLC analysis was performed
(Ultimate XB-C18, 250 mm × 4.6 mm, 5 μm) with a gradient from 100% buffer A (20 mM
triethylammonium acetate in water) to 40% buffer B (20 mM trie- thylammonium acetate in 50%
acetonitrile and 50% water) for 15 min. No significant decomposition was observed over 4-h
heating at 70°C (Figure 3.2.7), indicating that this Se-modification is relatively stable.

Figure 3.2.7. Thermostability study of SeU-RNA.
5’-USeUU-3’ was heated at 70°C for several hours. HPLC was monitored at both 260 and 307 nm
(retention time: 10.9 min).
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4

SYNTHESIS AND TRANSCRIPTION OF COLORED 4-SELENOURIDINE
TRIPHOSPHATE WITH A SINGLE ATOM SUBSTITUTION

4.1

Introduction

4.1.1

Se-modified RNA in nature
RNA is essential biological molecule that performs critical functions in genetic

information storage, transcription, protein synthesis and regulation. 2a, 27b The uniqueness of RNA
is greatly appreciated by the scientific society for its diversified structures and functions and its
extensive applications in nucleic acids-protein studies as well as therapeutic discoveries.

1b, 2b

Although RNA research areas are very activate worldwide, the comprehensive structure and
function of this biomolecule are not fully understood due to its complexity and often times due to
current technique limitations. Therefore, enormous artificial RNA modifications have been
developed to improve their chemical properties, to diversify their functionality and to increase
their stability and fidelity. There are over one hundred naturally occurring RNA modifications
have been discovered to date.5 Most of the modifications exist in tRNA including a seleniummodified nucleobase - 2-selenouridine. This selenium-modified uridine occurs at the wobble
position of the anticodon loop in several bacterial tRNAs (Escherichia coli, Clostridium
sticklandii, Methanococcus vannielii, etc.),5, 18 and its functionality has been fully characterized
recently by Sun et al. via chemical synthesis.9a The experimental date has demonstrated that the
Se-modification enhanced base pair fidelity by stabilizing the U/A base pair meanwhile
discouraging the U/G mismatch without causing significant perturbation to the RNA structure.
Moreover, the 2-Se-uridine triphosphate is recognizable by polymerase and Se-ribozyme is
active.
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4.1.2

4-Selenouridine

Figure 4.1.1. The UV spectrum of native UTP and 4SeUTP.
Native (red, λmax = 260 nm) and colored 4SeUTP (black. λmax = 365 nm). Inset: left: UTP
(colorless); right: 4SeUTP (yellow).
Our research lab has previously replaced the oxygen atom at position 4 of thymidine with
selenium.51a 4-selenium uridine nucleoside has been synthesized over decades ago; however, it
has been incorporated into RNA oligonucleotide only last year through solid phase synthesis.22
The enzymatic recognition of 4-seleno-uridne is unknown due to synthetic challenges of
triphosphates. Compare with 2-selenouridine, the 4-selenouridine and possesses a unique yellow
color with a UV absorption of 365 nm (Figure 4.1.1). This property is extremely useful for RNA
visualization, detection, as well as spectroscopic study and crystallography of RNAs and proteinRNA complexes and interactions. Compare to other bulky molecules for RNA visualization, our
new method only replace a single atom of the nucleobase to achieve such advancement. In
addition, heavy atom such as selenium is a suitable anomalous scattering center for multiwavelength anomalous dispersion (MAD) or single-wavelength anomalous dispersion (SAD) in
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protein and nucleic acid crystallography. Thus, this C=Se functionality provides another
advantage of seleno-modified nucleic acid research in X-ray crystallography.
4.1.3

Se

U-RNA synthesis

Figure 4.1.2. Hammerhead ribozyme.
A) Secondary structure of the non self-cleaving (mutant) SeU-hammerhead ribozymes, including
the wild-type (WHR) and crippled mutant (MHR). The mutant site and cleavage site are
indicated by arrows. Highly conserved bases are highlighted in grey. B) Secondary structure of
active SeU-hammerhead ribozyme with 5’-32P-labled RNA substrate.
The two strategies to synthesize the Se-modified RNAs include solid-phase synthesis and
transcription. The solid-phase synthesis method utilizes site-specific incorporation of the Senucleoside phosphoramidite. This method is applied to large-scale synthesis but limited to
relatively short RNAs (up to 50 nt.) due to technical issues. In addition, it requires multiple steps
in deprotection and purification. The chemical incorporation of 4-selenouridine into RNAs has
been achieved only last year.22 The enzymatic method on the other hand can allow synthesis of
longer RNAs (>50 nt.) in a large quantity (multiple milligrams). In addition, this method can
easily achieve multiple selenium atoms incorporation into RNA under the mild conditions. In
order to incorporate the 4-Se-uridine into RNA to further investigate the function and structure of
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the SeU-RNAs by in vitro transcription, 4-selenouridine triphosphate need to be synthesized first.
Herein we report the first synthesis of 4-selenouridine triphosphate (SeUTP) and the enzymatic
incorporation of SeUTP into non-coding RNAs. Both active and mutant hammerhead ribozymes
(Figure 4.1.2) were successfully transcribed and examined with SeUTP. The transcribed SeUhammerhead ribozyme is active, suggesting that the SeU-RNAs are useful in both function and
structure studies of non-coding RNAs.

4.2
4.2.1

General Experiment Section
4-Selenouridine triphosphate synthesis
Although the synthesis of 4-Se-uridine nucleoside has been achieved many years ago,54 it

was only recently incorporated into RNA oligonucleotide by our laboratory22 through 4-Seuridine phosphoramidite synthesis. This solid-phase synthetic method is able to incorporate
modified nucleobase into specific site of RNA with up to 50 nucleotides long. To obtain a longer
modified RNA with an efficient and mild approach, herein we report the first synthesis of 4selenouridine triphosphate and its incorporation into longer RNA via in vitro transcription. To
minimize the by-product formation, we protect the selenium atom during the chemical synthesis
with cyanoethyl group.9a, 20-22, 51 Thus the synthesis (Scheme 4.2.1) of
activation

of

the

commercial

available

4Se

UTP (5) started with the

uridine-nucleoside

1

with

2,4,6-

triisopropylbenzenesulfonyl chloride (TIBS-Cl) and 4-dimethylaminopyridine (DMAP) in
tetrahydrofuran (THF) at position 4. Then, without purification, a sodium selenide solution
(NCCH2CH2SeNa) generated by di(2-cyanoethyl) diselenide [(NCCH2CH2Se)2] and NaBH4 in
ethanol was slowly injected into reaction to obtain compound 2.20 Compound 2 was deprotected
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by triethylamine trihydrofluoride in THF at 40oC to obtain nucleoside 3. Compound 3 was
treated with 4% trifluoroacetic acid in dichloromethane to achieve nucleoside 4. Via a one-pot
synthesis, compound 4 was converted to protected 4-selenouridine triphosphate (4SeCH2CH2CNUTP,
compound 5) by treating with phosphorus oxychloride (POCl3), pyrophosphate, and bicarbonate
sequentially.19, 51a, 52
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Scheme 4.2.1. Chemical synthesis of 4SeUTP (5) and transcription of 4SeU-containing RNA.
a) TIBSCl, DMAP, THF; b) (NCCH2CH2Se)2, NaBH4, EtOH; c) Triethylamine trihydrofluoride,
THF, 40oC; d) 4% trifluoroacetic acid, CH2Cl2; e) POCl3, Me3PO4; (tri-n-butyl)amine,
pyrophosphate, N, N-dimethylformamide; the H2O hydrolysis; f) K2CO3 (0.05 M) in methanol;
g) RNA transcription.

4.2.1.1 Synthesis of 4-selenouridine
The starting material 1 (0.2 g, 0.37 mmol) and catalytic amount of 4,4’dimethylaminopyridine (DMAP, 3 mg) was dissolved in anhydrous THF under argon, followed
by adding diisopropylethylamine (DIPEA, 1.85 mmol) and the reaction was stirred at room
temperature. Then a solution of 2,4,6-trisopropylbenzenessulfonyl chloride (TIPCl, 0.56 mmol)
pre-dissolved in THF was added into reaction dropwisely. The reaction was stirred for 1 hour
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and monitored by TLC plate (5% methanol in dichloromethane). Without further purification, the
reaction mixture was slowly added into a clear solution of sodium selenide (NCCH2CH2SeNa)
pre-generated by adding ethanol (EtOH) into sodium borohydride (NaBH4, 2.2 mmol) and di(2cyanoethyl) diselenide [(NCCH2CH2Se)2, 1.83 mmol]. The reaction was stirred for another 1
hour and monitored by TLC plate (5% methanol in dichloromethane, Rf = 0.6). After the
reaction was complete, the crude compound 2 was dissolved in ethyl acetate and wash with
saturated sodium chloride solution. The organic layer was then separated, dried over magnesium
sulfate and evaporated into dryness. The compound was purified by flash column
chromatography to obtain a pure slight yellow foam compound.55 Then the pure compound 2 (0.1
g, 0.15 mmol) was dissolved in anhydrous THF and triethylamine trihydrofluoride (0.3 mmol)
was added into reaction at 40oC. The reaction was stirred for 2 hours and monitored by TLC
plate (7% methanol in dichloromethane). Once the reaction was complete, the crude reaction
mixture was dried under reduced pressure and re-dissolved in dichloromethane. Later, 4%
trifluoroacetic acid was added drop-wisely into the reaction until the pH reach 4. After the
reaction was complete, methanol (0.2 mL) was injected into the mixture and the organic layer
was washed by water twice, then isolated, dried over magnesium sulfate and evaporated under
reduced pressure. The crude compound 4 was purified by flash column chromatography and
characterized NMR (1H- and 13C-NMR) and ESI-TOF analyses. Compound 4: 1H NMR (400
MHz, CDCl3) δ: 8.09 (d, J = 7.0 Hz, 1H, H-6), 7.42 – 7.17 (m, 10H, aromatic and N-H), 6.83 (m,
4H, aromatic), 6.09 (d, J = 7.0 Hz, 1H, H-5), 5.83 (d, J = 2.2 Hz, 1H, H-1′), 5.71 – 5.51 (br, 1H,
2’-OH), 4.53 – 4.25 (m, 3H, H-3′, H-4′, 3′-OH), 3.80 (s, 6H, OMe), 3.58 – 3.41 (m, 3H, H-5′, H2′), 3.37 (t, J = 6.7 Hz, 2H, CH2-CN), 2.97 (t, J = 6.6 Hz, 2H, CH2-Se). 13C NMR (101 MHz,
CDCl3) δ: 174.71 (C-4), 153.73 (C-2), 139.23 (C-6) 157.70,143.20, 139.23, 134.30, 134.10,
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129.08, 127.09, 127.03, 126.17, 112.33 (Ar), 117.84 (CN), 105.79 (C-5), 91.95 (C-1′), 86.04 (CAr), 84.10 (C-4′), 75.33 (C-2′), 69.62 (C-3′), 61.11 (C-5’), 54.30 (OCH3), 19.61 (CH2CH2CN),
17.91(CH2-CN). Compound 3: 1H NMR (400 MHz, MeOD) δ: 8.32 (d, J = 7.0 Hz, 1H, H-5),
6.56 (d, J = 7.0 Hz, 1H, H-6), 5.80 (s, 1H, H-1′), 4.14 (m, 3H, H-2′, H-3′, H-4′), 3.98 (dd, 1H,
H5′), 3.79 (dd, 1H, H5′′), 3.38 (m, 2H, CH2-CN), 3.03 (m, 2H, CH2-Se). 13C NMR (101 MHz,
MeOD) δ: 175.15 (C-4), 153.57 (C-2), 139.94 (C-6), 117.85 (CN), 105.83 (C-5), 91.03 (C-1′),
83.54 (C-4′), 74.16 (C-2′), 67.39 (C-3′), 58.83 (C-5′), 19.19 (CH2CH2CN), 17.36 (CH2-CN).

4.2.1.2 Synthesis of 4-selenouridine triphosphate
Protected 4-Se-uridine nucleoside (4, 20 mg), tributylammonium pyrophosphate (2 eq.)
and proton-sponge (2 eq.) were weighted and dried in individual flasks under high vacuum for 3
hours and then filled with argon gas. Trimethyl phosphate (0.4 mL) was added into the flask that
containing compound 4 and the flask was stirred in an ice bath. Later a solution of proton-sponge
dissolved in trimethyl phosphate (0.3 mL) was injected into the solution of 4 at 0 oC. After 10
min stirring, a pre-diluted phosphorus oxychloride (POCl3; 9 mL, 2 eq.) in trimethyl phosphate
(90 mL) was added dropwisely into reaction mixture at 0 oC. The reaction was monitored by
TLC plate (isopropanol: ammonium hydroxide: water; v 5:3:2) and was completed in 2 hours.
Then tributylammonium pyrophosphate (2 eq., dissolved in 0.2 mL tributylamine and 0.4 mL
DMF) was fast injected into the reaction mixture at 0oC and allows the reaction vigorously to stir
for 5 min. Later the reaction was quenched with water (3 mL) and stirred for another 1 hr at the
room temperature and monitored by TLC plate. To obtain crude compound 5, a sodium chloride
(NaCl) solution (3 M NaCl, 0.5 mL) was added to the reaction flask, followed by adding pure
ethanol (14.5 mL) and freezing the suspension at -80 oC for 1 hr to allow the crude product to
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precipitate. Crude compound 5 was recovered by centrifugation for 20 min at 14,000 rpm in a
falcon tube (50 mL). The
purified by HPLC. Pure

4SeCH2CH2CN

4SeCH2CH2CN

UTP (5) pellet was re-dissolved in water, then analyzed and

UTP (5) was later characterized by NMR (1H-, 13C- and 31P-

NMR) and ESI-TOF analyses. 1H-NMR. The deprotection of compound 5 was carried out in a
potassium carbonate (K2CO3) solution in methanol (6 eq.) at room temperature and monitored by
TLC plate. After the reaction was complete, a NaCl/EtOH precipitation (described previously)
was performed to obtain the compound 6 (strong yellow color). Later the pure

4Se

UTP (6) was

characterized by NMR (1H-, 13C- and 31P-NMR) and ESI-TOF analyses. Compound 5: 1H NMR
(400 MHz, D2O) δ 8.11 (d, J = 7.1 Hz, 1H, H-5), 6.85 (d, J = 7.1 Hz, 1H, H-6), 5.85 (s, 1H, H-1′),
4.45 – 3.97 (m, 5H, H-2′, H-3′, H-4′, H-5′), 3.34 (t, J = 6.8 Hz, 2H, CH2-CN), 3.12 – 2.92 (m, 2H,
CH2-Se).

13

C NMR (101 MHz, MeOD) δ: 177.04 (C-4), 154.40 (C-2), 139.75 (C-6), 119.56

(CN), 107.60 (C-5), 89.56 (C-1′), 81.73 (C-4′), 73.77 (C-2′), 67.34 (C-3′), 63.08 (C-5′), 18.81
(CH2CH2CN), 17.31 (CH2-CN).
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P NMR (162 MHz, D2O) δ -10.65 (d, J = 19.8 Hz), -11.51 (d,

J = 20.1 Hz), -23.28 (t, J = 20.0 Hz). Compound 6: 1H NMR (400 MHz, D2O) δ 7.85 (d, J = 7.4
Hz, 1H, H-5), 6.87 (d, J = 7.4 Hz, 1H, H-6), 5.81 (d, J = 3.7 Hz, 1H, H-1′), 4.31 – 4.20 (m, 5H ,
H-2′, H-3′, H-4′, H-5′). 13C NMR (101 MHz, D2O) δ 191.58 (C-4), 154.15 (C-2), 134.45 (C-6),
117.10 (C-5), 88.96 (C-1′), 81.69 (C-4′), 73.31 (C-2′), 67.90 (C-3′), 56.43 (C-5′). 31P NMR (162
MHz, D2O) δ -9.99 (d, J = 19.3 Hz), -11.54 (d, J = 20.2 Hz), -23.15 (t, J = 20.1 Hz).

4.2.1.3 HPLC and UV analyses of 4SeCH2CH2CNUTP and 4SeUTP
The crude

4SeCH2CH2CN

UTP (4) was precipitated from reaction mixture after synthesis and

directly purified by reverse-phase high-performance liquid chromatography (RP-HPLC). The
purified 4SeCH2CH2CNUTP was characterized by NMR (1H, 13C and 31P), MS, HPLC and UV (Figure
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4.1.1). For the preservative purposes, the major potion of 4-selenouridine-triphosphate is kept in
the protected form (compound 4). Before transcription,

4SeCH2CH2CN

UTP (4) was treated with

K2CO3 (0.05 M in methanol) and was later precipitated with NaCl (3M) and ethanol, the pure
4Se

UTP is obtained. The maximal UV absorbance of native uridine triphosphate is 260 nm, the

maximal UV absorbance of the

4Se

U-triphosphate is 306 nm and the maximal UV absorbance of

the 4SeU-triphosphate is 365 nm and the compound itself is strong yellow color (Figure 4.1.1). In
the HPLC analysis, the native and selenium-modified UTPs were monitored with three
wavelengths (260, 310 and 360 nm with a buffer gradient of 100% buffer A (20 mM
triethylammonium acetate in water) to 25% buffer B (20 mM triethylammonium acetate in 50%
acetonitrile and 50% water) in 20 min. The HPLC and UV profiles are shown in Figure 4.1.1 and
Figure 4.2.1. The retention times of the native UTP,
and 14.7 min, respectively.

4SeCH2CH2CN

UTP and

4Se

UTP were 11.3, 17.8
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Figure 4.2.1. HPLC analyses of 4SeCH2CH2CNUTP and 4SeUTP at multiwavelength (260 nm, blue;
310 nm, red; 360 nm, green).
A) a1: Native UTP (retention time: 11.3 min); b1: 4SeCH2CH2CNUTP (retention time: 17.8 min); c1:
co-injection of both native UTP and 4SeCH2CH2CNUTP (retention time: 11.3 min and 17.8 min). B)
a2: Native UTP (retention time: 11.3 min); b2: 4SeUTP (retention time: 14.7 min); c2: co-injection
of both native UTP and 4SeUTP (retention time: 11.3 min and 14.7 min).
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4.2.2

4-Se-RNAs transcription

Figure 4.2.2. The ribozyme time course experiments.
A) The auto-radiography gel imagine of in vitro transcription with both native and 4SeU-RNA
under same experimental conditions; (left): transcription of the native RNA (mutant
hammerhead-ribozyme: MHR) with all native NTPs; the minor faster-moving band is the selfcleaved product (fragment); (right): transcription of the 4SeU-MHR with SeUTP and other native
NTPs. B) In vitro transcription of 4SeU-RNA under optimized conditions; (left): transcription of
the native RNA with all native NTPs under standard condition; (right): transcription of the 4SeUMHR with SeUTP and other native NTPs under optimized conditions.
To examine the

4Se

UTP compatibility with RNA polymerase in transcription, the

linearized plasmid templates for the crippled mutant hammerhead-ribozyme (MHR) were used
(Figure 4.1.2). The transcription result shows that T7 RNA polymerase can recognize 4SeUTP
(Figure 4.2.2A) and the transcript RNA contains 15 selenium atoms incorporation. Under the
same experimental conditions, the transcription of
native one. To increase the

4Se

4Se

UTP yields less product compare to the

U-RNA transcription yield, series of optimization experiments

were carried out including buffer pH adjustment and

4Se

UTP concentration alternation (Figure

4.2.5). From the result, we have observed that with higher

4Se

U-RNA concentration (4 times

higher than native UTP) at pH 7.5, the transcription yield of Se-modified RNA is comparable to
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the corresponding native RNA. The time-course experiments of both the native and

4Se

U-

modified mutant ribozymes were performed using the mutant hammerhead-ribozyme template.
The experiments are carried out under the same transcription condition as well as optimized
transcription conditions for comparison (Figure 4.2.2). Although the transcript hammerhead
ribozyme are mutant, partially self-cleaved fragment was still observed (minor faster-moving
band). Detailed experimental condition was discussed in materials and methods. This result
indicates that in the enzymatic catalysis, 4SeUTP does not cause significant interference.
4.2.2.1 Transcription analysis of the 4-Se-RNAs
The transcription experiment was carried out by following the standard procedures from
the manufacturer, Epicentre (AmpliScribe™ T7-Flash™ Transcription Kit). α-32P-ATP was used
as the radioactive labeling material for transcription experiments. Each transcription reaction (5
μL) contained ATP, CTP, GTP and UTP (0.5 mM each) or

4Se

UTP (2 mM for optimization),

linearized plasmid DNA template (50 ng/μL), DTT (10 mM), transcription buffer (1x) for T7
RNA polymerase, T7 RNA polymerase (10 U), and RNase-free water. At each time point of the
time-course experiments, a gel loading dye (5 μL) containing 100 mM EDTA was added to
quench the reaction, later the experiment was analyzed by denaturing PAGE (15% gel) and
autoradiography. The translated RNAs were MHR (Figure 4.1.2). To conform the integrity of
modified RNA, we transcribed an active self-cleavage RNA by using a linearized plasmid
template of wild-type hammerhead ribozyme (WHR, Figure 4.1.2). This transcribed RNA
contained 13 selenium atoms and unlike the MHR RNA, this WHR provides a clean cleaved
RNA product (Figure 4.2.3A), the integrity of WHR was confirmed by MALDI-TOF MS
analysis (Figure 4.2.3B).
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Figure 4.2.3. Wild-type ribozyme transcription.
(A)Wild-type native and 4-Se-modified ribozyme transcription with self-cleavage activity during
synthesis. (B) MALDI-TOF MS analysis of the SeU-WHR (molecular formula:
C543H672N218O385P56Se13); matrix: 3-hydroxypicolinic acid (3HPA, molecular formula: C6H5NO3);
mass of SeU-WHR and six matrix observed: 20010 (calc. 20010.6).

4.2.2.2 pH titration curve of 4-selenouridine
The 4-selenouridine solutions were adjusted to desired pH values in the buffer of 50 mM
Na2HPO4 at room temperature. The UV–Vis spectra were recorded every 0.1 pH unit between
pH 6–8 and every 0.2-0.5 pH unit between pH 4–6 and pH 8–10. The pH of each solution was
measured before and after its UV–Vis spectrum collection and the error was within ±0.02 pH
unit. The titration data was plotted and shown in Figure 4.2.4.
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Figure 4.2.4. Plot of wavelength (nm) versus pH for 4-selenouridine triphosphate.
The fitted titration curve yields the pKa value (7.85±0.02).
4.2.2.3 Transcription optimization of 4SeU-RNA
With standard transcription condition, the transcription yield of

4Se

U-RNA is lower than

native RNA (Figure 4.2.2A). To reach the native transcription level, optimization experiments
were carried out under different conditions. In the optimization experiments, we chose the
linearized plasmid template to transcibe mutant hammerhead ribozyme (Figure 4.1.2A) that
incorporates fifteen 4SeUTPs. We examined the transcription with different buffer pH values first
since the acidity of the imino group (3-NH) of 4SeUTP varies with the selenium modification (pKa
= 7.85, Figure 4.2.4). Eight transcription buffer pH were tested (pH 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5
and 9.0), the buffer pH was adjusted by adding concentrated HCl into the solution, the buffer
solution also includes 40 mM tris base, 6 mM MgCl2, 2 mM spermidine and 10 mM DTT. The
best yield comes from buffer pH 7.5 (Figure 4.2.5A), the standard native buffer condition is pH
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7.9. Under this optimized condition (buffer pH 7.5), higher concentrations of

4Se

UTP were also

examined and the transcription yield reached native transcription level when four times
concentration of

4Se

UTP was applied (Figure 4.2.5B). Later, this optimized condition with

transcription buffer pH 7.5 and higher

4Se

UTP concentration (4X) was applied to optimized

transcription time course experiment (Figure 4.2.2B) and catalytic activity studies (Figure 4.2.6).

Figure 4.2.5. Experimental results of transcription optimizations with 4SeUTP.
A) Optimization with different transcription buffer pH (5.5 to 9.0), standard transcription buffer
is pH 7.9. B) Optimization with different 4SeUTP concentration (0.2 mM to 2.0 mM), UTP
concentration in native control is 0.5 mM.

4.2.2.4 Catalytic activity analysis of the Se-RNAs
The

active

hammerhead

ribozymes

with

the

sequence

of

5’-

GGCAACCUGAUGAGGCCGAAAGGCCGAAACGUACA-3’ (Figure 4.1.2) is used in the
catalytic experiments. The transcription of both native and 4-Se-RNA used in this experiment
containing ATP, CTP, GTP and UTP (2.5 mM each) or

4Se

UTP (10 mM for optimization),

linearized plasmid DNA template (50 ng/μL), DTT (10 mM), transcription buffer (1x) for T7
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RNA polymerase, T7 RNA polymerase (20 U), and RNase-free water. The template used in this
transcription was a 55-nt long DNA duplex synthesized through solid-phase synthesis (5'TGTACGTTTCGGCCTTTCGGCCTCATCAGGTTGCCTATAGTGAGTCGTATTACGC-3'
and its complimentary sequence). The transcription reaction was performed at 37oC for 2 hours.
After transcription, the ribozymes were isolated from the template and primer. To compare
catalysis activity, both the native and 4-Se-ribozymes were adjusted to same concentration
(measured

by

UV).

For

ribozyme

digestion

experiment,

a

RNA

substrate

(5'-

ACCUGUACGUCGUUGCCUAA-3’) was synthesized through solid-phase synthesis (Figure
4.1.2) and was purified. In order to monitor the transcribed ribozyme catalytic activity, the
substrate was kinased with γ-32P-ATP at 5’ end by T4 polynucleotide kinase and the result was
observed by gel analysis and autoradiography. After ribozyme digestion, the RNA substrate was
cleaved and two fragments were obtained (11-nt and 9-nt in length respectively), but only the 5’32

P-labled end (11-nt) was visible by autoradiography. The digestion time-course analysis was

shown in Figure 4.2.6.

Figure 4.2.6. The transcription of the wild-type native and 4SeU-modified ribozymes.
Time-course of a 5’-32P-labled RNA substrate digestion by non self-cleaving native and 4SeUmodified ribozymes under same enzyme and substrate concentration. The experiments were
carried out at room temperature with 10 mM Mg2+ concentration. The pure RNA substrate is
used as the comparing marker.
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5

CONCLUSIONS

In summary, the atom-specific mutagenesis has been extensively applied in RNA
function and structure investigations, catalysis analysis, mechanism studies, as well as
therapeutics discoveries. The great advantage of the single-atom replacements is that they may
not only drastically improve beneficial properties of RNAs, such as thermostability and nuclease
resistance, but also preserve RNA structure integrity without significant alteration. The atomspecific modifications have indeed become a very convenient and practical strategy in the
fundamental research of nucleic acids, including structural and functional studies and drug
development. The selenium modifications in nucleic acids focus on the facilitation of
crystallization and phasing in X-ray crystallography for structure determination of nucleic acids,
nucleic acid–protein complexes, and nucleic acids complexed with small molecules as well as
metal ions. In addition to the crystal structure study, the selenium derivatization can facilitate
function studies, drug discoveries, and material investigations.
We have first synthesized the SeU-phosphoramidite, SeU-triphosphate (2SeUTP and 4SeUTP)
as well as SeU-RNAs. Our biophysical and structural studies on the SeU-RNAs indicate that the
native and Se-modified structures are virtually identical. The 2-Se-modification can largely
discriminate against the U/G wobble pair without significant impact on U/A pair, thereby
providing a unique chemical strategy to further enhance base pair fidelity. The Se-modification
will also provide a useful tool in X-ray crystal structure studies of RNAs and their protein
complexes. Moreover, we have demonstrated that the synthesized SeUTPs (2SeUTP and

4Se

UTP)

are stable and recognizable by T7 RNA polymerase. Under the optimized conditions, the
transcription yield of

Se

U-RNA can reach up to 85% of the corresponding native RNA.

Furthermore, the transcribed

Se

U-hammerhead ribozyme has the similar activity as the
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corresponding native, which suggests usefulness of SeU-RNAs in function and structure studies
of noncoding RNAs, including the Se-tRNAs. The atom-specific mutagenesis with selenium
opens a new research avenue for investigating base-pair recognition, fidelity and RNA
modification. This novel base pair (SeU/A) with higher specificity likely enables better
preservation of genetic information at the RNA level.
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APPENDICES
APPENDIX 1. Nucleic

Acid Mini Screen contains twenty-four unique reagents from Hampton

Research.
Nucleic Acid Mini Screen™
Tube
#

Precipitant

HR2-118 Reagent Formulation
Tube
#

Buffer

1. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
2. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
3. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

1. 0.040 M Sodium cacodylate trihydrate pH 5.5
2. 0.040 M Sodium cacodylate trihydrate pH 5.5
3. 0.040 M Sodium cacodylate trihydrate pH 5.5

4.
5.
6.
7.
8.
9.

4.
5.
6.
7.
8.
9.

10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol
10% v/v (+/-)-2-Methyl-2,4-pentanediol

0.040 M Sodium cacodylate trihydrate pH 5.5
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0
0.040 M Sodium cacodylate trihydrate pH 6.0

Tube
#

Polyamine

1. 0.020 M Hexamine cobalt(III) chloride
2. 0.020 M Hexamine cobalt(III) chloride
3. 0.020 M Hexamine cobalt(III) chloride
4.
5.
6.
7.
8.
9.

0.020 M Hexamine cobalt(III) chloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride

10. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

10. 0.040 M Sodium cacodylate trihydrate pH 6.0

10. 0.012 M Spermine tetrahydrochloride

11. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

11. 0.040 M Sodium cacodylate trihydrate pH 6.0
12. 0.040 M Sodium cacodylate trihydrate pH 6.0
13. 0.040 M Sodium cacodylate trihydrate pH 6.0

11. 0.012 M Spermine tetrahydrochloride
12. 0.012 M Spermine tetrahydrochloride
13. 0.012 M Spermine tetrahydrochloride

12. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
13. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
14. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
15. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0

0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride

Monovalent Ion

1. None
2. 0.080 M Sodium chloride
3. 0.012 M Sodium chloride,
0.080 M Potassium chloride
4. 0.040 M Lithium chloride
5. 0.080 M Potassium chloride
6. 0.080 M Potassium chloride
7. 0.080 M Sodium chloride
8. 0.080 M Sodium chloride
9. 0.080 M Sodium chloride,
0.012 M Potassium chloride
10. 0.012 M Sodium chloride,
0.080 M Potassium chloride
11. 0.080 M Sodium chloride
12. 0.080 M Potassium chloride
13. None
14. 0.080 M Potassium chloride
15. 0.080 M Potassium chloride

16. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
17. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

14.
15.
16.
17.

18. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

18. 0.040 M Sodium cacodylate trihydrate pH 7.0

18. 0.012 M Spermine tetrahydrochloride

19. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

19. 0.040 M Sodium cacodylate trihydrate pH 7.0

19. 0.012 M Spermine tetrahydrochloride

20. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
21. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
22. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

20. 0.040 M Sodium cacodylate trihydrate pH 7.0
21. 0.040 M Sodium cacodylate trihydrate pH 7.0
22. 0.040 M Sodium cacodylate trihydrate pH 7.0

20. 0.012 M Spermine tetrahydrochloride
21. 0.012 M Spermine tetrahydrochloride
22. 0.012 M Spermine tetrahydrochloride

16. 0.080 M Sodium chloride
17. 0.080 M Sodium chloride
18. 0.080 M Sodium chloride,
0.012 M Potassium chloride
19. 0.012 M Sodium chloride,
0.080 M Potassium chloride
20. 0.080 M Sodium chloride
21. 0.080 M Potassium chloride
22. 0.040 M Lithium chloride

23. 10% v/v (+/-)-2-Methyl-2,4-pentanediol
24. 10% v/v (+/-)-2-Methyl-2,4-pentanediol

23. 0.040 M Sodium cacodylate trihydrate pH 7.0
24. 0.040 M Sodium cacodylate trihydrate pH 7.0

23. 0.012 M Spermine tetrahydrochloride
24. 0.012 M Spermine tetrahydrochloride

23. 0.040 M Lithium chloride
24. None

0.040 M Sodium cacodylate trihydrate pH 7.0
0.040 M Sodium cacodylate trihydrate pH 7.0

14.
15.
16.
17.

Tube
#

0.012 M Spermine tetrahydrochloride
0.012 M Spermine tetrahydrochloride

Nucleic Acid Mini Screen contains twenty-four unique reagents.
To determine the formulation of each reagent, simply read across the page.

Tube
#

Divalent Ion

1. 0.020 M Magnesium chloride hexahydrate
2. 0.020 M Magnesium chloride hexahydrate
3. None
4.
5.
6.
7.
8.
9.

0.020 M Magnesium chloride hexahydrate
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate

10. None
11. 0.020 M Barium chloride
12. 0.020 M Barium chloride
13. 0.080 M Strontium chloride hexahydrate
14.
15.
16.
17.

0.020 M Magnesium chloride hexahydrate
None
0.020 M Magnesium chloride hexahydrate
None

18. 0.020 M Magnesium chloride hexahydrate
19. None
20. 0.020 M Barium chloride
21. 0.020 M Barium chloride
22. 0.080 M Strontium chloride hexahydrate,
0.020 M Magnesium chloride hexahydrate
23. 0.080 M Strontium chloride hexahydrate
24. 0.080 M Strontium chloride hexahydrate,
0.020 M Magnesium chloride hexahydrate
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APPENDIX 2. 1H NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine 6.
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APPENDIX 3. 13C NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine 6.
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APPENDIX 4. HRMS (ESI-TOF) of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-thiouridine
6.
50%MeOH+0.1%HCOOH, LeuEnk as ITSD 554.2615 Da

11:02:1703-Feb-2010

HUIYAN_SUN_5'DMTR_U2S_HRMS_ESI_NEG_HUANG_02032010 107 (1.991) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 2x3.00); Cm (73:129)

TOF MS ES4.43e4

561.1718

%

100

562.1750

563.1725
*
554.2615

0

548

550

552

554

559.3153

556

558

560

562

564

566

568

570

572

574

576

m/z
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APPENDIX 5. 1H NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2methylthiouridine 7.
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APPENDIX 6. 13C NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2methylthiouridine 7.
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APPENDIX 7. HRMS (ESI-TOF) of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2methylthiouridine compound 7.
100%MeOH+0.1%HCOOH, Leuink as ITSD

18:12:35 17-Sep-2010

HUIYAN_2_S_U_1_HUANG_HRMS_ESI_POS_091710_01 120 (2.233) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (120:141)

TOF MS ES+
3.28e4

577.2003

%

100

*
556.2771

551.3559

595.3790
590.4229

546.3981
542.4259

0

535

540

545

567.3516

550

555

560

565

570

601.3177 605.3292

575

580

585

590

595

600

605

611.3212

610

m/z

89

APPENDIX 8. 1H NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-selenouridine
8.

90

APPENDIX 9. 13C NMR spectra of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2-selenouridine
8.
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APPENDIX 10. HRMS (ESI-TOF) of 1-(5’-O-4,4’-dimethoxytrityl-beta-D-ribofuranosyl)-2selenouridine.
100%MeOH+0.5%NH4OH, Leuink as ITSD

17:23:44 01-Nov-2010

HUIYAN_2_SE_U_HRMS_HUANG_ESI_NEG_110110 8 (0.149) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 2x3.00); Cm (8:20)

TOF MS ES2.55e3

609.1136

%

100

607.1158

610.1281

611.1226
605.1223
608.1210

612.1277
599.5347

0

599
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603.1392
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603

613.1365
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607

608

609

610
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612

613

614

615

616

617

618

619

620

621

m/z

APPENDIX 11. HRMS (ESI-TOF) of compound 9a and 9b.
50%MeOH+0.5%NH4OH, LeuEnk as ITSD 554.2615 Da

11:14:3303-Feb-2010

HUIYAN_SUN_2SE)2'_TBDMS_HRMS_ESI_NEG_HUANG_02032010 76 (1.408) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 2x3.00); Cm (5:85)

TOF MS ES1.01e4

723.1990

100

%

721.1992

724.2017

725.2001

720.2026

722.2031

719.2021

726.2047
727.2040

0

739.1891

711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741

m/z

92

APPENDIX 12. 1H NMR spectra of 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-Dribofuranosyl)-2-cyanoethylselanyluridine 10a.

93

APPENDIX 13. 13C NMR spectra of 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-Dribofuranosyl)-2-cyanoethylselanyluridine 10a.

94

APPENDIX 14. 1H NMR spectra of 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-Dribofuranosyl)-2-cyanoethylselanyluridine 10b.
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APPENDIX 15. 13C NMR spectra of 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-beta-Dribofuranosyl)-2-cyanoethylselanyluridine 10b.
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APPENDIX 16. HRMS (ESI-TOF) of 1-(2’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-betaD-ribofuranosyl)-2-cyanoethylselanyluridine 10a.
50%MeOH+0.1%HCOOH, LeuEnk as ITSD 556.2771Da

16:31:5612-Feb-2010

HUIYAN_SUN_SECN_UP_HRMS_ESI_POS_HUANG_021210 165 (3.070) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (158:165)

TOF MS ES+
633

778.2464

100

776.2532

%

779.2567

780.2577
775.2579
777.2489

781.2505

774.2406

772.5355

0
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m/z

787

APPENDIX 17. HRMS (ESI-TOF) of 1-(3’-O-tert-butyldimethylsilyl-5’-O-4,4’-dimethoxytrityl-betaD-ribofuranosyl)-2-cyanoethylselanyluridine 10b.
50%MeOH+0.1%HCOOH, LeuEnk as ITSD 556.2771Da

16:40:4112-Feb-2010

HUIYAN_SUN_SECN_DOWN_HRMS_ESI_POS_HUANG_021210 55 (1.022) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 2x3.00); Cm (37:57)

TOF MS ES+
5.87e3

778.2401

100

%

776.2449

779.2433

780.2423

775.2399
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APPENDIX 18. 1H NMR spectra of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,Ndiisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2cyanoethylselanyluridine 11.

98

APPENDIX 19. 13C NMR spectra of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,Ndiisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2cyanoethylselanyluridine 11.
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APPENDIX 20. 31P NMR spectra of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,Ndiisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2cyanoethylselanyluridine 11.
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APPENDIX 21. HRMS (ESI-TOF) of 1-[2’-O-tert-butyldimethylsilyl-3’-O-(2-cyanoethyl-N,Ndiisopropylamino) phosphoramidite-5’-O-(4,4’-dimethoxytrityl-beta-D-ribofuranosyl)]-2cyanoethylselanyluridine 11.
iin MeOH+0.1%HCOOH, leuink as ITSD

11:48:30 20-Aug-2010

HUIYAN_SUN_DIMER_ESI_POS_HRMS_HUANG_082010_01 355 (6.609) AM (Cen,4, 80.00, Ar,5000.0,906.83,0.70); Sm (SG, 2x3.00); Cm (294:428)
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APPENDIX 22. MALDI-TOF MS of 2-Se-U 12mer (5'-AUCACCSeUCCUUA-3’) [M+H+]+ = 3740.3
(calc. 3740.2).
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APPENDIX 23. MALDI-TOF MS of 2-Se-U 12mer (5'-AAUGCSeUGCACUG-3') [M+H+]+ = 3859.4
(calc. 3859.3).
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APPENDIX 24. MALDI-TOF MS of 2-Se-U 8mer (5’-GUAUASeUAC-3’) [M+H+]+ = 2558.7 ( calc.
2558.5).
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APPENDIX 25. 1H-NMR of 2SeUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 26. 13C-NMR of 2SeUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 27. 31P-NMR of 2SeUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 28. Mass spectrum of 2SeUTP. Molecular formula: C9H14N2O14P3Se-. HRMS (ESITOF): [M-H+]- = 546.8812 (calc. 546.8829).
50%MeOH+0.5%NH4OH
17:19:44 18-Jul-2011

HUIYAN_2SEUTP_07171011_HUANG_071811_HRMS_LEUINK AS ITSD 84 (1.563) AM (Cen,4, 80.00, Ar,5000.0,554.26,0.70); Sm (SG, 3x3.00)
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APPENDIX 29. 1H NMR spectra of 5’-O-4,4’-dimethoxytrity -4-cyanoethylselanyluridine.
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APPENDIX 30. 13C NMR spectra of 5’-O-4,4’-dimethoxytrity -4-cyanoethylselanyluridine
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APPENDIX 31. 1H NMR spectra of 4-cyanoethylselanyluridine.
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APPENDIX 32. 13C NMR spectra of 4-cyanoethylselanyluridine.
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APPENDIX 33. 1H-NMR of 4SeCH2CH2CNUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 34. 13C-NMR of 4SeCH2CH2CNUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 35. 31P-NMR of 4SeCH2CH2CNUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 36. 1H-NMR of 4SeUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 37. 13C-NMR of 4SeUTP (with Na+ and triethylammonium as counter ions).
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APPENDIX 38. 31P-NMR of 4SeUTP (with Na+ and triethylammonium as counter ions).
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50%MeOH

15:33:45 17-Aug-2012

HUIYAN_4SEUTP-D1_HUANG-ACCU_08-17-2012_ESI-NEG01 148 (1.581) AM (Cen,2, 80.00, Ar,5000.0,554.26,0.70); Cm
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APPENDIX 39. Mass spectrum of 4SeCH2CH2CNUTP. HRMS (ESI-TOF): [M-H+]- = 599.9092 (calc.
599.9094).

20x in 50%MeOH+0.5%NH4OH

14:57:48 14-Sep-2012

%

HUIYAN_4SEUTP-20120914_HUANG-ACCU_09-14-2012_ESI-NEG01 133 (1.405) AM (Cen,2, 80.00, Ar,5000.0,554.26,0.70); Cm (101:160)
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APPENDIX 40. Mass spectrum of 4SeUTP. HRMS (ESI-TOF): [M-H+]- = 546.8835 (calc.
546.8829).

